{
 "metadata": {
  "name": "",
  "signature": "sha256:8925ba816a2cd8ce69ffa5e35e3811ecad5137b059723041216c2a9c8b086597"
 },
 "nbformat": 3,
 "nbformat_minor": 0,
 "worksheets": [
  {
   "cells": [
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import requests\n",
      "import sys\n",
      "import argparse\n",
      "import pprint\n",
      "import json"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 1
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "\"\"\"\n",
      "python script retrieves uniprot sequence and metadata for list of uniprot ids\n",
      "\n",
      "\"\"\"\n",
      "import requests\n",
      "import sys\n",
      "import argparse\n",
      "\n",
      "url = 'http://www.uniprot.org/'\n",
      "\n",
      "\n",
      "def parse_uniprot(uni_txt):\n",
      "    \"\"\"\n",
      "    Parses the text of metadata retrieved from uniprot.org.\n",
      "\n",
      "    Only a few fields have been parsed, but this provides a\n",
      "    template for the other fields.\n",
      "\n",
      "    A single description is generated from joining alternative\n",
      "    descriptions.\n",
      "\n",
      "    Returns a dictionary with the main UNIPROT ACC as keys.\n",
      "    \"\"\"\n",
      "\n",
      "    tag = None\n",
      "    uniprot_id = None\n",
      "    metadata_by_acc = {}\n",
      "    for l in uni_txt.splitlines():\n",
      "        ttag = l[:5].strip()\n",
      "        if ttag and ttag != tag:\n",
      "            tag = ttag\n",
      "        line = l[5:].strip()\n",
      "        words = line.split()\n",
      "        if tag == \"ID\":\n",
      "            uniprot_id = words[0]\n",
      "            is_reviewed = words[1].startswith('Reviewed')\n",
      "            length = int(words[2])\n",
      "            metadata_by_acc[uniprot_id] = {\n",
      "                'id': uniprot_id,\n",
      "                'is_reviewed': is_reviewed,\n",
      "                'length': length,\n",
      "                'sequence': '',\n",
      "                'accs': [],\n",
      "                'gene': [],\n",
      "            }\n",
      "            entry = metadata_by_acc[uniprot_id]\n",
      "        if tag == \"SQ\":\n",
      "            if words[0] != \"SEQUENCE\":\n",
      "                entry['sequence'] += ''.join(words)\n",
      "        if tag == \"AC\":\n",
      "            accs = [w.replace(\";\", \"\") for w in words]\n",
      "            entry['accs'].extend(accs)\n",
      "        if tag == \"GN\":\n",
      "            if 'gene' not in entry:\n",
      "                entry['gene'] = []\n",
      "            parts = words[0].split(\"=\")\n",
      "            entry['gene'].append(parts[1])\n",
      "\n",
      "        if tag == \"DR\":\n",
      "            if 'PDB' in words[0]:\n",
      "                if 'pdb' not in entry:\n",
      "                    entry['pdb'] = words[1][:-1]\n",
      "                if 'pdbs' not in entry:\n",
      "                    entry['pdbs'] = []\n",
      "                entry['pdbs'].append(words[1][:-1])\n",
      "            if 'RefSeq' in words[0]:\n",
      "                if 'refseq' not in entry:\n",
      "                    entry['refseq'] = []\n",
      "                ids = [w[:-1] for w in words[1:]]\n",
      "                entry['refseq'].extend(ids)\n",
      "            if 'KEGG' in words[0]:\n",
      "                if 'kegg' not in entry:\n",
      "                    entry['kegg'] = []\n",
      "                ids = [w[:-1] for w in words[1:]]\n",
      "                ids = filter(lambda w: len(w) > 1, ids)\n",
      "                entry['kegg'].extend(ids)\n",
      "            if 'GO' in words[0]:\n",
      "                if 'go' not in entry:\n",
      "                    entry['go'] = []\n",
      "                entry['go'].append(' '.join(words[1:]))\n",
      "            if 'Pfam' in words[0]:\n",
      "                if 'pfam' not in entry:\n",
      "                    entry['pfam'] = []\n",
      "                entry['pfam'].append(words[1][:-1])\n",
      "\n",
      "        if tag == \"OS\":\n",
      "            if 'organism' not in entry:\n",
      "                entry['organism'] = \"\"\n",
      "            entry['organism'] += line\n",
      "    #     if tag == \"DE\":\n",
      "    #         if 'descriptions' not in entry:\n",
      "    #             entry['descriptions'] = []\n",
      "    #         entry['descriptions'].append(line)\n",
      "    #     if tag == \"CC\":\n",
      "    #         if 'comment' not in entry:\n",
      "    #             entry['comment'] = ''\n",
      "    #         entry['comment'] += line + '\\n'\n",
      "\n",
      "    # for entry in metadata_by_acc.values():\n",
      "    #     descriptions = entry['descriptions']\n",
      "    #     for i in reversed(range(len(descriptions))):\n",
      "    #         description = descriptions[i]\n",
      "    #         if 'Short' in description or 'Full' in description:\n",
      "    #             j = description.find('=')\n",
      "    #             descriptions[i] = description[j + 1:].replace(';', '')\n",
      "    #         else:\n",
      "    #             del descriptions[i]\n",
      "    #     entry['description'] = '; '.join(descriptions)\n",
      "\n",
      "    return metadata_by_acc\n",
      "\n",
      "\n",
      "\n",
      "def pull_uni(ids, format='txt'):\n",
      "    \"\"\" request entries by uniprot acc using batch retrieval\n",
      "    Args:\n",
      "        ids: list of ids to retrieve\n",
      "        format: txt by default\n",
      "        possible formats:\n",
      "        txt, xml, rdf, fasta, gff\"\"\"\n",
      "\n",
      "    tool = 'batch/'\n",
      "    if type(ids) is not list:\n",
      "        ids = [ids]\n",
      "    query = ' '.join(ids)\n",
      "    query = list(set(query.split()))\n",
      "    queries = [query[i:i + 100] for i in xrange(0, len(query), 100)]\n",
      "    data = {'format': format}\n",
      "    responses = [\n",
      "        requests.post(url + tool, data=data, files={'file': ' '.join(query)}) for query in queries]\n",
      "    uni_txt = ''.join([response.text for response in responses])\n",
      "    #return uni_txt\n",
      "    res = parse_uniprot(uni_txt)\n",
      "    return res\n",
      "\n",
      "\n",
      "\n",
      "import sys\n",
      "\n",
      "if __name__ == '__main__':\n",
      "    ids = ['P01116', 'P15056']\n",
      "    res = pull_uni(ids)\n",
      "    #sys.stdout = open('log.txt', 'a')\n",
      "    F = open('resfile.pkl', 'wb')\n",
      "    import pickle\n",
      "    pickle.dump(res, F)\n",
      "    F.close()\n",
      "    import json\n",
      "    R = json.dumps(res)\n",
      "    json.dump(res, fp=open('res4json.txt', 'w'), indent=4)\n",
      "    json.dump(res, fp=open('res6json.json', 'w'), indent=4)\n",
      "    print json.dumps(res, sort_keys=True, indent=4, separators=(',', ': '))\n",
      "\n",
      "\n",
      "\n",
      "    #print >> afile, res"
     ],
     "language": "python",
     "metadata": {},
     "outputs": []
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "url = 'http://www.uniprot.org/'\n",
      "ids = ['P01116', 'P15056']\n",
      "\n",
      "def pull_uni(ids, format='txt'):\n",
      "    \"\"\" request entries by uniprot acc using batch retrieval\n",
      "    Args:\n",
      "        ids: list of ids to retrieve\n",
      "        format: txt by default\n",
      "        possible formats:\n",
      "        txt, xml, rdf, fasta, gff\"\"\"\n",
      "\n",
      "    tool = 'batch/'\n",
      "    if type(ids) is not list:\n",
      "        ids = [ids]\n",
      "    query = ' '.join(ids)\n",
      "    query = list(set(query.split()))\n",
      "    queries = [query[i:i + 100] for i in xrange(0, len(query), 100)]\n",
      "    data = {'format': format}\n",
      "    responses = [\n",
      "        requests.post(url + tool, data=data, files={'file': ' '.join(query)}) for query in queries]\n",
      "    uni_txt = ''.join([response.text for response in responses])\n",
      "    return uni_txt\n",
      "    #res = parse_uniprot(uni_txt)\n",
      "    #return res\n",
      "\n",
      "uni_txt = pull_uni(ids)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 2
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "print uni_txt"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "ID   BRAF_HUMAN              Reviewed;         766 AA.\n",
        "AC   P15056; A4D1T4; B6HY61; B6HY62; B6HY63; B6HY64; B6HY65; B6HY66;\n",
        "AC   Q13878; Q3MIN6; Q9UDP8; Q9Y6T3;\n",
        "DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.\n",
        "DT   19-JUL-2004, sequence version 4.\n",
        "DT   09-JUL-2014, entry version 183.\n",
        "DE   RecName: Full=Serine/threonine-protein kinase B-raf;\n",
        "DE            EC=2.7.11.1;\n",
        "DE   AltName: Full=Proto-oncogene B-Raf;\n",
        "DE   AltName: Full=p94;\n",
        "DE   AltName: Full=v-Raf murine sarcoma viral oncogene homolog B1;\n",
        "GN   Name=BRAF; Synonyms=BRAF1, RAFB1;\n",
        "OS   Homo sapiens (Human).\n",
        "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
        "OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
        "OC   Catarrhini; Hominidae; Homo.\n",
        "OX   NCBI_TaxID=9606;\n",
        "RN   [1]\n",
        "RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND\n",
        "RP   PHOSPHORYLATION AT THR-373.\n",
        "RC   TISSUE=Testis;\n",
        "RX   PubMed=1508179;\n",
        "RA   Stephens R.M., Sithanandam G., Copeland T.D., Kaplan D.R., Rapp U.R.,\n",
        "RA   Morrison D.K.;\n",
        "RT   \"95-kilodalton B-Raf serine/threonine kinase: identification of the\n",
        "RT   protein and its major autophosphorylation site.\";\n",
        "RL   Mol. Cell. Biol. 12:3733-3742(1992).\n",
        "RN   [2]\n",
        "RP   SEQUENCE REVISION TO 31-33.\n",
        "RA   Albert S., Wixler L., Rapp U.R.;\n",
        "RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.\n",
        "RN   [3]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\n",
        "RG   NIEHS SNPs program;\n",
        "RL   Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.\n",
        "RN   [4]\n",
        "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\n",
        "RX   PubMed=12690205; DOI=10.1126/science.1083423;\n",
        "RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,\n",
        "RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,\n",
        "RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,\n",
        "RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,\n",
        "RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,\n",
        "RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,\n",
        "RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,\n",
        "RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,\n",
        "RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,\n",
        "RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,\n",
        "RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,\n",
        "RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,\n",
        "RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,\n",
        "RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,\n",
        "RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,\n",
        "RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,\n",
        "RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,\n",
        "RA   Mural R.J., Adams M.D., Tsui L.-C.;\n",
        "RT   \"Human chromosome 7: DNA sequence and biology.\";\n",
        "RL   Science 300:767-772(2003).\n",
        "RN   [5]\n",
        "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\n",
        "RX   PubMed=12853948; DOI=10.1038/nature01782;\n",
        "RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,\n",
        "RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,\n",
        "RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,\n",
        "RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,\n",
        "RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,\n",
        "RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,\n",
        "RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,\n",
        "RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,\n",
        "RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,\n",
        "RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,\n",
        "RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,\n",
        "RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,\n",
        "RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,\n",
        "RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,\n",
        "RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,\n",
        "RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,\n",
        "RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,\n",
        "RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,\n",
        "RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,\n",
        "RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,\n",
        "RA   Waterston R.H., Wilson R.K.;\n",
        "RT   \"The DNA sequence of human chromosome 7.\";\n",
        "RL   Nature 424:157-164(2003).\n",
        "RN   [6]\n",
        "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].\n",
        "RC   TISSUE=Liver;\n",
        "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\n",
        "RG   The MGC Project Team;\n",
        "RT   \"The status, quality, and expansion of the NIH full-length cDNA\n",
        "RT   project: the Mammalian Gene Collection (MGC).\";\n",
        "RL   Genome Res. 14:2121-2127(2004).\n",
        "RN   [7]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-200.\n",
        "RC   TISSUE=Placenta;\n",
        "RX   PubMed=1630826;\n",
        "RA   Eychene A., Barnier J.V., Apiou F., Dutrillaux B., Calothy G.;\n",
        "RT   \"Chromosomal assignment of two human B-raf(Rmil) proto-oncogene loci:\n",
        "RT   B-raf-1 encoding the p94Braf/Rmil and B-raf-2, a processed\n",
        "RT   pseudogene.\";\n",
        "RL   Oncogene 7:1657-1660(1992).\n",
        "RN   [8]\n",
        "RP   PROTEIN SEQUENCE OF 2-51; 56-95; 151-158; 189-199; 253-260; 294-354;\n",
        "RP   361-424; 444-507; 510-522; 559-570; 579-626; 663-680; 692-698;\n",
        "RP   702-719; 727-735 AND 753-766, CLEAVAGE OF INITIATOR METHIONINE,\n",
        "RP   ACETYLATION AT ALA-2, PHOSPHORYLATION AT SER-365; THR-396; SER-399;\n",
        "RP   THR-401 AND SER-729, AND IDENTIFICATION BY MASS SPECTROMETRY.\n",
        "RC   TISSUE=Colon carcinoma, and Hepatoma;\n",
        "RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Zebisch A., Kolch W.;\n",
        "RL   Submitted (DEC-2008) to UniProtKB.\n",
        "RN   [9]\n",
        "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-766.\n",
        "RC   TISSUE=Testis;\n",
        "RX   PubMed=2284096;\n",
        "RA   Sithanandam G., Kolch W., Duh F.-M., Rapp U.R.;\n",
        "RT   \"Complete coding sequence of a human B-raf cDNA and detection of B-raf\n",
        "RT   protein kinase with isozyme specific antibodies.\";\n",
        "RL   Oncogene 5:1775-1780(1990).\n",
        "RN   [10]\n",
        "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 381-766, DISEASE, AND CHROMOSOMAL\n",
        "RP   REARRANGEMENT.\n",
        "RC   TISSUE=Brain;\n",
        "RX   PubMed=18974108; DOI=10.1158/0008-5472.CAN-08-2097;\n",
        "RA   Jones D.T.W., Kocialkowski S., Liu L., Pearson D.M., Backlund L.M.,\n",
        "RA   Ichimura K., Collins V.P.;\n",
        "RT   \"Tandem duplication producing a novel oncogenic BRAF fusion gene\n",
        "RT   defines the majority of pilocytic astrocytomas.\";\n",
        "RL   Cancer Res. 68:8673-8677(2008).\n",
        "RN   [11]\n",
        "RP   NUCLEOTIDE SEQUENCE [MRNA] OF 439-766.\n",
        "RX   PubMed=3043188;\n",
        "RA   Ikawa S., Fukui M., Ueyama Y., Tamaoki N., Yamamoto T., Toyoshima K.;\n",
        "RT   \"B-raf, a new member of the raf family, is activated by DNA\n",
        "RT   rearrangement.\";\n",
        "RL   Mol. Cell. Biol. 8:2651-2654(1988).\n",
        "RN   [12]\n",
        "RP   PHOSPHORYLATION AT SER-365 BY SGK1.\n",
        "RX   PubMed=11410590; DOI=10.1074/jbc.M102808200;\n",
        "RA   Zhang B.H., Tang E.D., Zhu T., Greenberg M.E., Vojtek A.B., Guan K.L.;\n",
        "RT   \"Serum- and glucocorticoid-inducible kinase SGK phosphorylates and\n",
        "RT   negatively regulates B-Raf.\";\n",
        "RL   J. Biol. Chem. 276:31620-31626(2001).\n",
        "RN   [13]\n",
        "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401, AND IDENTIFICATION\n",
        "RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\n",
        "RC   TISSUE=Cervix carcinoma;\n",
        "RX   PubMed=16964243; DOI=10.1038/nbt1240;\n",
        "RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;\n",
        "RT   \"A probability-based approach for high-throughput protein\n",
        "RT   phosphorylation analysis and site localization.\";\n",
        "RL   Nat. Biotechnol. 24:1285-1292(2006).\n",
        "RN   [14]\n",
        "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\n",
        "RC   TISSUE=Cervix carcinoma;\n",
        "RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;\n",
        "RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,\n",
        "RA   Greff Z., Keri G., Stemmann O., Mann M.;\n",
        "RT   \"Kinase-selective enrichment enables quantitative phosphoproteomics of\n",
        "RT   the kinome across the cell cycle.\";\n",
        "RL   Mol. Cell 31:438-448(2008).\n",
        "RN   [15]\n",
        "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401; SER-446; SER-447\n",
        "RP   AND SER-729, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE\n",
        "RP   ANALYSIS].\n",
        "RC   TISSUE=Cervix carcinoma;\n",
        "RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\n",
        "RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\n",
        "RA   Elledge S.J., Gygi S.P.;\n",
        "RT   \"A quantitative atlas of mitotic phosphorylation.\";\n",
        "RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\n",
        "RN   [16]\n",
        "RP   SUBUNIT, INTERACTION WITH DGKH, AND PHOSPHORYLATION AT THR-753 BY\n",
        "RP   MAPK1.\n",
        "RX   PubMed=19710016; DOI=10.1074/jbc.M109.043604;\n",
        "RA   Yasuda S., Kai M., Imai S., Takeishi K., Taketomi A., Toyota M.,\n",
        "RA   Kanoh H., Sakane F.;\n",
        "RT   \"Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf\n",
        "RT   heterodimerization.\";\n",
        "RL   J. Biol. Chem. 284:29559-29570(2009).\n",
        "RN   [17]\n",
        "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\n",
        "RC   TISSUE=Leukemic T-cell;\n",
        "RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;\n",
        "RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\n",
        "RA   Rodionov V., Han D.K.;\n",
        "RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling\n",
        "RT   reveals system-wide modulation of protein-protein interactions.\";\n",
        "RL   Sci. Signal. 2:RA46-RA46(2009).\n",
        "RN   [18]\n",
        "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\n",
        "RC   TISSUE=Cervix carcinoma;\n",
        "RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;\n",
        "RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,\n",
        "RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,\n",
        "RA   Mann M.;\n",
        "RT   \"Quantitative phosphoproteomics reveals widespread full\n",
        "RT   phosphorylation site occupancy during mitosis.\";\n",
        "RL   Sci. Signal. 3:RA3-RA3(2010).\n",
        "RN   [19]\n",
        "RP   INTERACTION WITH KSR2, SUBUNIT, CATALYTIC ACTIVITY, FUNCTION, AND\n",
        "RP   MUTAGENESIS OF LYS-483.\n",
        "RX   PubMed=21441910; DOI=10.1038/nature09860;\n",
        "RA   Brennan D.F., Dar A.C., Hertz N.T., Chao W.C., Burlingame A.L.,\n",
        "RA   Shokat K.M., Barford D.;\n",
        "RT   \"A Raf-induced allosteric transition of KSR stimulates phosphorylation\n",
        "RT   of MEK.\";\n",
        "RL   Nature 472:366-369(2011).\n",
        "RN   [20]\n",
        "RP   INTERACTION WITH PRMT5, METHYLATION AT ARG-671, CHARACTERIZATION OF\n",
        "RP   VARIANT CRC GLU-600, AND MUTAGENESIS OF ARG-671.\n",
        "RX   PubMed=21917714; DOI=10.1126/scisignal.2001936;\n",
        "RA   Andreu-Perez P., Esteve-Puig R., de Torre-Minguela C.,\n",
        "RA   Lopez-Fauqued M., Bech-Serra J.J., Tenbaum S., Garcia-Trevijano E.R.,\n",
        "RA   Canals F., Merlino G., Avila M.A., Recio J.A.;\n",
        "RT   \"Protein arginine methyltransferase 5 regulates ERK1/2 signal\n",
        "RT   transduction amplitude and cell fate through CRAF.\";\n",
        "RL   Sci. Signal. 4:RA58-RA58(2011).\n",
        "RN   [21]\n",
        "RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729, AND IDENTIFICATION\n",
        "RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\n",
        "RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\n",
        "RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,\n",
        "RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,\n",
        "RA   Blagoev B.;\n",
        "RT   \"System-wide temporal characterization of the proteome and\n",
        "RT   phosphoproteome of human embryonic stem cell differentiation.\";\n",
        "RL   Sci. Signal. 4:RS3-RS3(2011).\n",
        "RN   [22]\n",
        "RP   UBIQUITINATION BY RNF149.\n",
        "RX   PubMed=22628551; DOI=10.1074/jbc.M111.319822;\n",
        "RA   Hong S.W., Jin D.H., Shin J.S., Moon J.H., Na Y.S., Jung K.A.,\n",
        "RA   Kim S.M., Kim J.C., Kim K.P., Hong Y.S., Lee J.L., Choi E.K.,\n",
        "RA   Lee J.S., Kim T.W.;\n",
        "RT   \"Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type\n",
        "RT   v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).\";\n",
        "RL   J. Biol. Chem. 287:24017-24025(2012).\n",
        "RN   [23]\n",
        "RP   UBIQUITINATION AT LYS-578, AND MUTAGENESIS OF LYS-578.\n",
        "RX   PubMed=23907581; DOI=10.1038/srep02344;\n",
        "RA   An L., Jia W., Yu Y., Zou N., Liang L., Zhao Y., Fan Y., Cheng J.,\n",
        "RA   Shi Z., Xu G., Li G., Yang J., Zhang H.;\n",
        "RT   \"Lys63-linked polyubiquitination of BRAF at lysine 578 is required for\n",
        "RT   BRAF-mediated signaling.\";\n",
        "RL   Sci. Rep. 3:2344-2344(2013).\n",
        "RN   [24]\n",
        "RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 444-719 IN COMPLEX WITH\n",
        "RP   INHIBITOR.\n",
        "RX   PubMed=18287029; DOI=10.1073/pnas.0711741105;\n",
        "RA   Tsai J., Lee J.T., Wang W., Zhang J., Cho H., Mamo S., Bremer R.,\n",
        "RA   Gillette S., Kong J., Haass N.K., Sproesser K., Li L., Smalley K.S.,\n",
        "RA   Fong D., Zhu Y.L., Marimuthu A., Nguyen H., Lam B., Liu J., Cheung I.,\n",
        "RA   Rice J., Suzuki Y., Luu C., Settachatgul C., Shellooe R., Cantwell J.,\n",
        "RA   Kim S.H., Schlessinger J., Zhang K.Y., West B.L., Powell B.,\n",
        "RA   Habets G., Zhang C., Ibrahim P.N., Hirth P., Artis D.R., Herlyn M.,\n",
        "RA   Bollag G.;\n",
        "RT   \"Discovery of a selective inhibitor of oncogenic B-Raf kinase with\n",
        "RT   potent antimelanoma activity.\";\n",
        "RL   Proc. Natl. Acad. Sci. U.S.A. 105:3041-3046(2008).\n",
        "RN   [25]\n",
        "RP   VARIANTS LNCR VAL-466 AND ARG-597.\n",
        "RX   PubMed=12460919;\n",
        "RA   Naoki K., Chen T.-H., Richards W.G., Sugarbaker D.J., Meyerson M.;\n",
        "RT   \"Missense mutations of the BRAF gene in human lung adenocarcinoma.\";\n",
        "RL   Cancer Res. 62:7001-7003(2002).\n",
        "RN   [26]\n",
        "RP   VARIANTS CANCER GLU-464; VAL-464; ALA-466; GLU-466; VAL-466; ALA-469;\n",
        "RP   GLU-469; LYS-586; LEU-595; ARG-596; ARG-597; VAL-597; GLU-600 AND\n",
        "RP   ASP-600, AND CHARACTERIZATION OF VARIANTS CANCER VAL-464; ALA-469;\n",
        "RP   VAL-597 AND GLU-600.\n",
        "RX   PubMed=12068308; DOI=10.1038/nature00766;\n",
        "RA   Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S.,\n",
        "RA   Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N.,\n",
        "RA   Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J.,\n",
        "RA   Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S.,\n",
        "RA   Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C.,\n",
        "RA   Shipley J., Hargrave D., Pritchard-Jones K., Maitland N.,\n",
        "RA   Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A.,\n",
        "RA   Flanagan A., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T.,\n",
        "RA   Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R.,\n",
        "RA   Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.;\n",
        "RT   \"Mutations of the BRAF gene in human cancer.\";\n",
        "RL   Nature 417:949-954(2002).\n",
        "RN   [27]\n",
        "RP   VARIANTS CRC ILE-462; SER-463; GLU-464; GLU-600 AND GLU-601.\n",
        "RX   PubMed=12198537; DOI=10.1038/418934a;\n",
        "RA   Rajagopalan H., Bardelli A., Lengauer C., Kinzler K.W., Vogelstein B.,\n",
        "RA   Velculescu V.E.;\n",
        "RT   \"Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.\";\n",
        "RL   Nature 418:934-934(2002).\n",
        "RN   [28]\n",
        "RP   VARIANTS NHL ALA-469; ARG-469 AND GLY-594.\n",
        "RX   PubMed=14612909; DOI=10.1038/sj.bjc.6601371;\n",
        "RA   Lee J.W., Yoo N.J., Soung Ark W.S., Kim S.Y., Lee J.H., Park J.Y.,\n",
        "RA   Cho Y.G., Kim C.J., Ko Y.H., Kim S.H., Nam S.W., Lee J.Y., Lee S.H.;\n",
        "RT   \"BRAF mutations in non-Hodgkin's lymphoma.\";\n",
        "RL   Br. J. Cancer 89:1958-1960(2003).\n",
        "RN   [29]\n",
        "RP   CHARACTERIZATION OF VARIANT MELANOMA GLU-600.\n",
        "RX   PubMed=14500344;\n",
        "RA   Hingorani S.R., Jacobetz M.A., Robertson G.P., Herlyn M.,\n",
        "RA   Tuveson D.A.;\n",
        "RT   \"Suppression of BRAF(V599E) in human melanoma abrogates\n",
        "RT   transformation.\";\n",
        "RL   Cancer Res. 63:5198-5202(2003).\n",
        "RN   [30]\n",
        "RP   VARIANTS CFC1 PRO-246; ARG-257; GLU-469; PHE-485; GLU-499; LYS-501;\n",
        "RP   GLY-501 AND ASP-581.\n",
        "RX   PubMed=16474404; DOI=10.1038/ng1749;\n",
        "RA   Niihori T., Aoki Y., Narumi Y., Neri G., Cave H., Verloes A.,\n",
        "RA   Okamoto N., Hennekam R.C.M., Gillessen-Kaesbach G., Wieczorek D.,\n",
        "RA   Kavamura M.I., Kurosawa K., Ohashi H., Wilson L., Heron D.,\n",
        "RA   Bonneau D., Corona G., Kaname T., Naritomi K., Baumann C.,\n",
        "RA   Matsumoto N., Kato K., Kure S., Matsubara Y.;\n",
        "RT   \"Germline KRAS and BRAF mutations in cardio-facio-cutaneous\n",
        "RT   syndrome.\";\n",
        "RL   Nat. Genet. 38:294-296(2006).\n",
        "RN   [31]\n",
        "RP   VARIANT [LARGE SCALE ANALYSIS] GLU-600.\n",
        "RX   PubMed=16959974; DOI=10.1126/science.1133427;\n",
        "RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,\n",
        "RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,\n",
        "RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,\n",
        "RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,\n",
        "RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,\n",
        "RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;\n",
        "RT   \"The consensus coding sequences of human breast and colorectal\n",
        "RT   cancers.\";\n",
        "RL   Science 314:268-274(2006).\n",
        "RN   [32]\n",
        "RP   VARIANTS CFC1 ARG-257; ALA-467; SER-468; GLU-469; PHE-485; GLU-499;\n",
        "RP   LYS-501; GLY-501; ASP-581; LEU-595 AND VAL-596.\n",
        "RX   PubMed=16439621; DOI=10.1126/science.1124642;\n",
        "RA   Rodriguez-Viciana P., Tetsu O., Tidyman W.E., Estep A.L., Conger B.A.,\n",
        "RA   Cruz M.S., McCormick F., Rauen K.A.;\n",
        "RT   \"Germline mutations in genes within the MAPK pathway cause cardio-\n",
        "RT   facio-cutaneous syndrome.\";\n",
        "RL   Science 311:1287-1290(2006).\n",
        "RN   [33]\n",
        "RP   VARIANTS [LARGE SCALE ANALYSIS] SER-301; ALA-469; VAL-469; SER-581;\n",
        "RP   ARG-596; ARG-597; VAL-597; GLU-600; GLU-600 AND GLU-600.\n",
        "RX   PubMed=17344846; DOI=10.1038/nature05610;\n",
        "RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,\n",
        "RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,\n",
        "RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,\n",
        "RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,\n",
        "RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,\n",
        "RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,\n",
        "RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,\n",
        "RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,\n",
        "RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,\n",
        "RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,\n",
        "RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,\n",
        "RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;\n",
        "RT   \"Patterns of somatic mutation in human cancer genomes.\";\n",
        "RL   Nature 446:153-158(2007).\n",
        "RN   [34]\n",
        "RP   VARIANTS CFC1 PRO-241; PRO-244; PRO-246; ARG-257; LYS-262; SER-468;\n",
        "RP   GLU-469; GLU-499; ASN-499; ASP-580; ASP-581 AND LEU-595.\n",
        "RX   PubMed=18042262; DOI=10.1111/j.1399-0004.2007.00931.x;\n",
        "RA   Schulz A.L., Albrecht B., Arici C., van der Burgt I., Buske A.,\n",
        "RA   Gillessen-Kaesbach G., Heller R., Horn D., Hubner C.A., Korenke G.C.,\n",
        "RA   Konig R., Kress W., Kruger G., Meinecke P., Mucke J., Plecko B.,\n",
        "RA   Rossier E., Schinzel A., Schulze A., Seemanova E., Seidel H.,\n",
        "RA   Spranger S., Tuysuz B., Uhrig S., Wieczorek D., Kutsche K., Zenker M.;\n",
        "RT   \"Mutation and phenotypic spectrum in patients with cardio-facio-\n",
        "RT   cutaneous and Costello syndrome.\";\n",
        "RL   Clin. Genet. 73:62-70(2008).\n",
        "RN   [35]\n",
        "RP   VARIANT LEOPARD3 PRO-241, VARIANTS NS7 CYS-531 AND VAL-597, VARIANTS\n",
        "RP   CFC1 PHE-245; PRO-246; ARG-257; LYS-275; GLU-469; PHE-485; ASN-499;\n",
        "RP   LYS-501; PRO-525; LEU-595; ARG-599; GLN-601; GLU-638 AND ARG-709, AND\n",
        "RP   VARIANTS ARG-241 AND MET-241.\n",
        "RX   PubMed=19206169; DOI=10.1002/humu.20955;\n",
        "RA   Sarkozy A., Carta C., Moretti S., Zampino G., Digilio M.C.,\n",
        "RA   Pantaleoni F., Scioletti A.P., Esposito G., Cordeddu V., Lepri F.,\n",
        "RA   Petrangeli V., Dentici M.L., Mancini G.M., Selicorni A., Rossi C.,\n",
        "RA   Mazzanti L., Marino B., Ferrero G.B., Silengo M.C., Memo L.,\n",
        "RA   Stanzial F., Faravelli F., Stuppia L., Puxeddu E., Gelb B.D.,\n",
        "RA   Dallapiccola B., Tartaglia M.;\n",
        "RT   \"Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous\n",
        "RT   syndromes: molecular diversity and associated phenotypic spectrum.\";\n",
        "RL   Hum. Mutat. 30:695-702(2009).\n",
        "RN   [36]\n",
        "RP   VARIANT CRC GLU-600.\n",
        "RX   PubMed=23263490; DOI=10.1038/ng.2503;\n",
        "RG   CORGI Consortium;\n",
        "RG   WGS500 Consortium;\n",
        "RA   Palles C., Cazier J.B., Howarth K.M., Domingo E., Jones A.M.,\n",
        "RA   Broderick P., Kemp Z., Spain S.L., Guarino Almeida E., Salguero I.,\n",
        "RA   Sherborne A., Chubb D., Carvajal-Carmona L.G., Ma Y., Kaur K.,\n",
        "RA   Dobbins S., Barclay E., Gorman M., Martin L., Kovac M.B., Humphray S.,\n",
        "RA   Lucassen A., Holmes C.C., Bentley D., Donnelly P., Taylor J.,\n",
        "RA   Petridis C., Roylance R., Sawyer E.J., Kerr D.J., Clark S., Grimes J.,\n",
        "RA   Kearsey S.E., Thomas H.J., McVean G., Houlston R.S., Tomlinson I.;\n",
        "RT   \"Germline mutations affecting the proofreading domains of POLE and\n",
        "RT   POLD1 predispose to colorectal adenomas and carcinomas.\";\n",
        "RL   Nat. Genet. 45:136-144(2013).\n",
        "CC   -!- FUNCTION: Protein kinase involved in the transduction of mitogenic\n",
        "CC       signals from the cell membrane to the nucleus. May play a role in\n",
        "CC       the postsynaptic responses of hippocampal neuron. Phosphorylates\n",
        "CC       MAP2K1, and thereby contributes to the MAP kinase signal\n",
        "CC       transduction pathway.\n",
        "CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.\n",
        "CC   -!- COFACTOR: Binds 2 zinc ions per subunit (By similarity).\n",
        "CC   -!- ENZYME REGULATION: Activity is increased by EGF and HGF.\n",
        "CC   -!- SUBUNIT: Monomer. Homodimer. Heterodimerizes with RAF1, and the\n",
        "CC       heterodimer possesses a highly increased kinase activity compared\n",
        "CC       to the respective homodimers or monomers. Heterodimerization is\n",
        "CC       mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2\n",
        "CC       activation can induce a negative feedback that promotes the\n",
        "CC       dissociation of the heterodimer by phosphorylating BRAF at Thr-\n",
        "CC       753. Found in a complex with at least BRAF, HRAS, MAP2K1, MAPK3\n",
        "CC       and RGS14. Interacts with RIT1. Interacts (via N-terminus) with\n",
        "CC       RGS14 (via RBD domains); the interaction mediates the formation of\n",
        "CC       a ternary complex with RAF1, a ternary complex inhibited by GNAI1\n",
        "CC       (By similarity). Interacts with DGKH. Interacts with PRMT5.\n",
        "CC       Interacts with KSR2.\n",
        "CC   -!- INTERACTION:\n",
        "CC       Self; NbExp=8; IntAct=EBI-365980, EBI-365980;\n",
        "CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-365980, EBI-352572;\n",
        "CC       Q61097:Ksr1 (xeno); NbExp=3; IntAct=EBI-365980, EBI-1536336;\n",
        "CC       Q13233:MAP3K1; NbExp=2; IntAct=EBI-365980, EBI-49776;\n",
        "CC       P04049:RAF1; NbExp=39; IntAct=EBI-365980, EBI-365996;\n",
        "CC       Q99N57:Raf1 (xeno); NbExp=3; IntAct=EBI-365980, EBI-397757;\n",
        "CC       Q8CGE9:Rgs12 (xeno); NbExp=2; IntAct=EBI-365980, EBI-7340552;\n",
        "CC       Q15349:RPS6KA2; NbExp=2; IntAct=EBI-365980, EBI-1384149;\n",
        "CC       Q13114:TRAF3; NbExp=2; IntAct=EBI-365980, EBI-357631;\n",
        "CC       P31946:YWHAB; NbExp=3; IntAct=EBI-365980, EBI-359815;\n",
        "CC       P63104:YWHAZ; NbExp=3; IntAct=EBI-365980, EBI-347088;\n",
        "CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity). Cytoplasm. Cell\n",
        "CC       membrane (By similarity). Note=Colocalizes with RGS14 and RAF1 in\n",
        "CC       both the cytoplasm and membranes (By similarity).\n",
        "CC   -!- TISSUE SPECIFICITY: Brain and testis.\n",
        "CC   -!- PTM: Phosphorylation at Ser-365 by SGK1 inhibits its activity.\n",
        "CC   -!- PTM: Methylation at Arg-671 decreases stability and kinase\n",
        "CC       activity.\n",
        "CC   -!- PTM: Ubiquitinated by RNF149; which leads to proteasomal\n",
        "CC       degradation. Polyubiquitinated at Lys-578 in response to EGF.\n",
        "CC   -!- DISEASE: Note=Defects in BRAF are found in a wide range of\n",
        "CC       cancers.\n",
        "CC   -!- DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease\n",
        "CC       characterized by malignant lesions arising from the inner wall of\n",
        "CC       the large intestine (the colon) and the rectum. Genetic\n",
        "CC       alterations are often associated with progression from\n",
        "CC       premalignant lesion (adenoma) to invasive adenocarcinoma. Risk\n",
        "CC       factors for cancer of the colon and rectum include colon polyps,\n",
        "CC       long-standing ulcerative colitis, and genetic family history.\n",
        "CC       Note=The disease may be caused by mutations affecting the gene\n",
        "CC       represented in this entry.\n",
        "CC   -!- DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy\n",
        "CC       affecting tissues of the lung. The most common form of lung cancer\n",
        "CC       is non-small cell lung cancer (NSCLC) that can be divided into 3\n",
        "CC       major histologic subtypes: squamous cell carcinoma,\n",
        "CC       adenocarcinoma, and large cell lung cancer. NSCLC is often\n",
        "CC       diagnosed at an advanced stage and has a poor prognosis. Note=The\n",
        "CC       gene represented in this entry is involved in disease\n",
        "CC       pathogenesis.\n",
        "CC   -!- DISEASE: Familial non-Hodgkin lymphoma (NHL) [MIM:605027]: Cancer\n",
        "CC       that starts in cells of the lymph system, which is part of the\n",
        "CC       body's immune system. NHLs can occur at any age and are often\n",
        "CC       marked by enlarged lymph nodes, fever and weight loss. Note=The\n",
        "CC       gene represented in this entry is involved in disease\n",
        "CC       pathogenesis.\n",
        "CC   -!- DISEASE: Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]: A\n",
        "CC       multiple congenital anomaly disorder characterized by a\n",
        "CC       distinctive facial appearance, heart defects and mental\n",
        "CC       retardation. Heart defects include pulmonic stenosis, atrial\n",
        "CC       septal defects and hypertrophic cardiomyopathy. Some affected\n",
        "CC       individuals present with ectodermal abnormalities such as sparse,\n",
        "CC       friable hair, hyperkeratotic skin lesions and a generalized\n",
        "CC       ichthyosis-like condition. Typical facial features are similar to\n",
        "CC       Noonan syndrome. They include high forehead with bitemporal\n",
        "CC       constriction, hypoplastic supraorbital ridges, downslanting\n",
        "CC       palpebral fissures, a depressed nasal bridge, and posteriorly\n",
        "CC       angulated ears with prominent helices. Note=The disease is caused\n",
        "CC       by mutations affecting the gene represented in this entry.\n",
        "CC   -!- DISEASE: Noonan syndrome 7 (NS7) [MIM:613706]: A form of Noonan\n",
        "CC       syndrome, a disease characterized by short stature, facial\n",
        "CC       dysmorphic features such as hypertelorism, a downward eyeslant and\n",
        "CC       low-set posteriorly rotated ears, and a high incidence of\n",
        "CC       congenital heart defects and hypertrophic cardiomyopathy. Other\n",
        "CC       features can include a short neck with webbing or redundancy of\n",
        "CC       skin, deafness, motor delay, variable intellectual deficits,\n",
        "CC       multiple skeletal defects, cryptorchidism, and bleeding diathesis.\n",
        "CC       Individuals with Noonan syndrome are at risk of juvenile\n",
        "CC       myelomonocytic leukemia, a myeloproliferative disorder\n",
        "CC       characterized by excessive production of myelomonocytic cells.\n",
        "CC       Note=The disease is caused by mutations affecting the gene\n",
        "CC       represented in this entry.\n",
        "CC   -!- DISEASE: LEOPARD syndrome 3 (LEOPARD3) [MIM:613707]: A disorder\n",
        "CC       characterized by lentigines, electrocardiographic conduction\n",
        "CC       abnormalities, ocular hypertelorism, pulmonic stenosis,\n",
        "CC       abnormalities of genitalia, retardation of growth, and\n",
        "CC       sensorineural deafness. Note=The disease is caused by mutations\n",
        "CC       affecting the gene represented in this entry.\n",
        "CC   -!- DISEASE: Note=A chromosomal aberration involving BRAF is found in\n",
        "CC       pilocytic astrocytomas. A tandem duplication of 2 Mb at 7q34 leads\n",
        "CC       to the expression of a KIAA1549-BRAF fusion protein with a\n",
        "CC       constitutive kinase activity and inducing cell transformation.\n",
        "CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr\n",
        "CC       protein kinase family. RAF subfamily.\n",
        "CC   -!- SIMILARITY: Contains 1 phorbol-ester/DAG-type zinc finger.\n",
        "CC   -!- SIMILARITY: Contains 1 protein kinase domain.\n",
        "CC   -!- SIMILARITY: Contains 1 RBD (Ras-binding) domain.\n",
        "CC   -!- SEQUENCE CAUTION:\n",
        "CC       Sequence=AAD43193.1; Type=Erroneous gene model prediction;\n",
        "CC       Sequence=CAQ43111.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;\n",
        "CC       Sequence=CAQ43112.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;\n",
        "CC       Sequence=CAQ43113.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;\n",
        "CC       Sequence=CAQ43114.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;\n",
        "CC       Sequence=CAQ43115.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;\n",
        "CC       Sequence=CAQ43116.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;\n",
        "CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology\n",
        "CC       and Haematology;\n",
        "CC       URL=\"http://atlasgeneticsoncology.org/Genes/BRAFID828.html\";\n",
        "CC   -----------------------------------------------------------------------\n",
        "CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms\n",
        "CC   Distributed under the Creative Commons Attribution-NoDerivs License\n",
        "CC   -----------------------------------------------------------------------\n",
        "DR   EMBL; M95712; AAA35609.2; -; mRNA.\n",
        "DR   EMBL; AC006344; AAD43193.1; ALT_SEQ; Genomic_DNA.\n",
        "DR   EMBL; EU600171; ACD11489.1; -; Genomic_DNA.\n",
        "DR   EMBL; AC006347; AAD15551.1; -; Genomic_DNA.\n",
        "DR   EMBL; CH236950; EAL24023.1; -; Genomic_DNA.\n",
        "DR   EMBL; BC101757; AAI01758.1; -; mRNA.\n",
        "DR   EMBL; BC112079; AAI12080.1; -; mRNA.\n",
        "DR   EMBL; X65187; CAA46301.1; -; Genomic_DNA.\n",
        "DR   EMBL; M21001; AAA96495.1; -; mRNA.\n",
        "DR   EMBL; AM989472; CAQ43111.1; ALT_INIT; mRNA.\n",
        "DR   EMBL; AM989473; CAQ43112.1; ALT_INIT; mRNA.\n",
        "DR   EMBL; AM989474; CAQ43113.1; ALT_INIT; mRNA.\n",
        "DR   EMBL; AM989475; CAQ43114.1; ALT_INIT; mRNA.\n",
        "DR   EMBL; AM989476; CAQ43115.1; ALT_INIT; mRNA.\n",
        "DR   EMBL; AM989477; CAQ43116.1; ALT_INIT; mRNA.\n",
        "DR   CCDS; CCDS5863.1; -.\n",
        "DR   PIR; A57977; TVHUBF.\n",
        "DR   RefSeq; NP_004324.2; NM_004333.4.\n",
        "DR   UniGene; Hs.550061; -.\n",
        "DR   UniGene; Hs.600998; -.\n",
        "DR   UniGene; Hs.605380; -.\n",
        "DR   UniGene; Hs.659507; -.\n",
        "DR   PDB; 1UWH; X-ray; 2.95 A; A/B=448-723.\n",
        "DR   PDB; 1UWJ; X-ray; 3.50 A; A/B=448-723.\n",
        "DR   PDB; 2FB8; X-ray; 2.90 A; A/B=445-723.\n",
        "DR   PDB; 2L05; NMR; -; A=149-232.\n",
        "DR   PDB; 3C4C; X-ray; 2.57 A; A/B=444-721.\n",
        "DR   PDB; 3D4Q; X-ray; 2.80 A; A/B=433-726.\n",
        "DR   PDB; 3IDP; X-ray; 2.70 A; A/B=434-727.\n",
        "DR   PDB; 3II5; X-ray; 2.79 A; A/B=432-726.\n",
        "DR   PDB; 3NY5; X-ray; 1.99 A; A/B/C/D=153-237.\n",
        "DR   PDB; 3OG7; X-ray; 2.45 A; A/B=449-766.\n",
        "DR   PDB; 3PPJ; X-ray; 3.70 A; A/B=432-726.\n",
        "DR   PDB; 3PPK; X-ray; 3.00 A; A/B=432-726.\n",
        "DR   PDB; 3PRF; X-ray; 2.90 A; A/B=432-726.\n",
        "DR   PDB; 3PRI; X-ray; 3.50 A; A/B=432-726.\n",
        "DR   PDB; 3PSB; X-ray; 3.40 A; A/B=433-726.\n",
        "DR   PDB; 3PSD; X-ray; 3.60 A; A/B=433-726.\n",
        "DR   PDB; 3Q4C; X-ray; 3.20 A; A/B=432-726.\n",
        "DR   PDB; 3Q96; X-ray; 3.10 A; A/B=446-727.\n",
        "DR   PDB; 3SKC; X-ray; 3.20 A; A/B=432-726.\n",
        "DR   PDB; 3TV4; X-ray; 3.40 A; A/B=432-726.\n",
        "DR   PDB; 3TV6; X-ray; 3.30 A; A/B=432-726.\n",
        "DR   PDB; 4DBN; X-ray; 3.15 A; A/B=445-726.\n",
        "DR   PDB; 4E26; X-ray; 2.55 A; A/B=432-726.\n",
        "DR   PDB; 4E4X; X-ray; 3.60 A; A/B=432-726.\n",
        "DR   PDB; 4EHE; X-ray; 3.30 A; A/B=432-726.\n",
        "DR   PDB; 4EHG; X-ray; 3.50 A; A/B=432-726.\n",
        "DR   PDB; 4FC0; X-ray; 2.95 A; A/B=445-726.\n",
        "DR   PDB; 4FK3; X-ray; 2.65 A; A/B=444-723.\n",
        "DR   PDB; 4G9C; X-ray; 3.50 A; A/B=432-726.\n",
        "DR   PDB; 4G9R; X-ray; 3.20 A; A/B=432-726.\n",
        "DR   PDB; 4H58; X-ray; 3.10 A; A/B/C=448-722.\n",
        "DR   PDB; 4JVG; X-ray; 3.09 A; A/B/C/D=444-723.\n",
        "DR   PDB; 4KSP; X-ray; 2.93 A; A/B=445-726.\n",
        "DR   PDB; 4KSQ; X-ray; 3.30 A; A/B=445-726.\n",
        "DR   PDB; 4MBJ; X-ray; 3.60 A; A/B=432-723.\n",
        "DR   PDB; 4PP7; X-ray; 3.40 A; A/B=432-726.\n",
        "DR   PDBsum; 1UWH; -.\n",
        "DR   PDBsum; 1UWJ; -.\n",
        "DR   PDBsum; 2FB8; -.\n",
        "DR   PDBsum; 2L05; -.\n",
        "DR   PDBsum; 3C4C; -.\n",
        "DR   PDBsum; 3D4Q; -.\n",
        "DR   PDBsum; 3IDP; -.\n",
        "DR   PDBsum; 3II5; -.\n",
        "DR   PDBsum; 3NY5; -.\n",
        "DR   PDBsum; 3OG7; -.\n",
        "DR   PDBsum; 3PPJ; -.\n",
        "DR   PDBsum; 3PPK; -.\n",
        "DR   PDBsum; 3PRF; -.\n",
        "DR   PDBsum; 3PRI; -.\n",
        "DR   PDBsum; 3PSB; -.\n",
        "DR   PDBsum; 3PSD; -.\n",
        "DR   PDBsum; 3Q4C; -.\n",
        "DR   PDBsum; 3Q96; -.\n",
        "DR   PDBsum; 3SKC; -.\n",
        "DR   PDBsum; 3TV4; -.\n",
        "DR   PDBsum; 3TV6; -.\n",
        "DR   PDBsum; 4DBN; -.\n",
        "DR   PDBsum; 4E26; -.\n",
        "DR   PDBsum; 4E4X; -.\n",
        "DR   PDBsum; 4EHE; -.\n",
        "DR   PDBsum; 4EHG; -.\n",
        "DR   PDBsum; 4FC0; -.\n",
        "DR   PDBsum; 4FK3; -.\n",
        "DR   PDBsum; 4G9C; -.\n",
        "DR   PDBsum; 4G9R; -.\n",
        "DR   PDBsum; 4H58; -.\n",
        "DR   PDBsum; 4JVG; -.\n",
        "DR   PDBsum; 4KSP; -.\n",
        "DR   PDBsum; 4KSQ; -.\n",
        "DR   PDBsum; 4MBJ; -.\n",
        "DR   PDBsum; 4PP7; -.\n",
        "DR   ProteinModelPortal; P15056; -.\n",
        "DR   SMR; P15056; 149-283, 448-723.\n",
        "DR   BioGrid; 107141; 41.\n",
        "DR   DIP; DIP-1045N; -.\n",
        "DR   IntAct; P15056; 36.\n",
        "DR   MINT; MINT-1574728; -.\n",
        "DR   STRING; 9606.ENSP00000288602; -.\n",
        "DR   BindingDB; P15056; -.\n",
        "DR   ChEMBL; CHEMBL5145; -.\n",
        "DR   DrugBank; DB00398; Sorafenib.\n",
        "DR   GuidetoPHARMACOLOGY; 1943; -.\n",
        "DR   PhosphoSite; P15056; -.\n",
        "DR   DMDM; 50403720; -.\n",
        "DR   MaxQB; P15056; -.\n",
        "DR   PaxDb; P15056; -.\n",
        "DR   PRIDE; P15056; -.\n",
        "DR   DNASU; 673; -.\n",
        "DR   Ensembl; ENST00000288602; ENSP00000288602; ENSG00000157764.\n",
        "DR   GeneID; 673; -.\n",
        "DR   KEGG; hsa:673; -.\n",
        "DR   UCSC; uc003vwc.4; human.\n",
        "DR   CTD; 673; -.\n",
        "DR   GeneCards; GC07M140424; -.\n",
        "DR   GeneReviews; BRAF; -.\n",
        "DR   H-InvDB; HIX0167822; -.\n",
        "DR   HGNC; HGNC:1097; BRAF.\n",
        "DR   HPA; CAB004552; -.\n",
        "DR   HPA; HPA001328; -.\n",
        "DR   MIM; 114500; phenotype.\n",
        "DR   MIM; 115150; phenotype.\n",
        "DR   MIM; 164757; gene.\n",
        "DR   MIM; 211980; phenotype.\n",
        "DR   MIM; 605027; phenotype.\n",
        "DR   MIM; 613706; phenotype.\n",
        "DR   MIM; 613707; phenotype.\n",
        "DR   neXtProt; NX_P15056; -.\n",
        "DR   Orphanet; 1340; Cardiofaciocutaneous syndrome.\n",
        "DR   Orphanet; 54595; Craniopharyngioma.\n",
        "DR   Orphanet; 58017; Hairy cell leukemia.\n",
        "DR   Orphanet; 99872; Hashimoto-Pritzker syndrome.\n",
        "DR   Orphanet; 500; LEOPARD syndrome.\n",
        "DR   Orphanet; 648; Noonan syndrome.\n",
        "DR   Orphanet; 251612; Pilocytic astrocytoma.\n",
        "DR   PharmGKB; PA25408; -.\n",
        "DR   eggNOG; COG0515; -.\n",
        "DR   HOVERGEN; HBG001886; -.\n",
        "DR   InParanoid; P15056; -.\n",
        "DR   KO; K04365; -.\n",
        "DR   OMA; HRTRTSS; -.\n",
        "DR   OrthoDB; EOG7F5128; -.\n",
        "DR   PhylomeDB; P15056; -.\n",
        "DR   TreeFam; TF317006; -.\n",
        "DR   BRENDA; 2.7.10.2; 2681.\n",
        "DR   Reactome; REACT_111102; Signal Transduction.\n",
        "DR   Reactome; REACT_116125; Disease.\n",
        "DR   Reactome; REACT_13685; Neuronal System.\n",
        "DR   SignaLink; P15056; -.\n",
        "DR   ChiTaRS; BRAF; human.\n",
        "DR   EvolutionaryTrace; P15056; -.\n",
        "DR   GeneWiki; BRAF_(gene); -.\n",
        "DR   GenomeRNAi; 673; -.\n",
        "DR   NextBio; 2776; -.\n",
        "DR   PMAP-CutDB; P15056; -.\n",
        "DR   PRO; PR:P15056; -.\n",
        "DR   ArrayExpress; P15056; -.\n",
        "DR   Bgee; P15056; -.\n",
        "DR   CleanEx; HS_BRAF; -.\n",
        "DR   Genevestigator; P15056; -.\n",
        "DR   GO; GO:0005829; C:cytosol; TAS:Reactome.\n",
        "DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.\n",
        "DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.\n",
        "DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.\n",
        "DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.\n",
        "DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.\n",
        "DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.\n",
        "DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IEA:Ensembl.\n",
        "DR   GO; GO:0005515; F:protein binding; IPI:IntAct.\n",
        "DR   GO; GO:0004672; F:protein kinase activity; IDA:BHF-UCL.\n",
        "DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.\n",
        "DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:Reactome.\n",
        "DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:BHF-UCL.\n",
        "DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.\n",
        "DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.\n",
        "DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.\n",
        "DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome.\n",
        "DR   GO; GO:0009887; P:organ morphogenesis; TAS:ProtInc.\n",
        "DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL.\n",
        "DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.\n",
        "DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB.\n",
        "DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.\n",
        "DR   GO; GO:0006468; P:protein phosphorylation; IDA:BHF-UCL.\n",
        "DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.\n",
        "DR   GO; GO:0070849; P:response to epidermal growth factor; IDA:BHF-UCL.\n",
        "DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.\n",
        "DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome.\n",
        "DR   GO; GO:0007268; P:synaptic transmission; TAS:Reactome.\n",
        "DR   InterPro; IPR020454; DAG/PE-bd.\n",
        "DR   InterPro; IPR011009; Kinase-like_dom.\n",
        "DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.\n",
        "DR   InterPro; IPR000719; Prot_kinase_dom.\n",
        "DR   InterPro; IPR017441; Protein_kinase_ATP_BS.\n",
        "DR   InterPro; IPR003116; Raf-like_ras-bd.\n",
        "DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.\n",
        "DR   InterPro; IPR008271; Ser/Thr_kinase_AS.\n",
        "DR   InterPro; IPR029071; Ubiquitin-rel_dom.\n",
        "DR   Pfam; PF00130; C1_1; 1.\n",
        "DR   Pfam; PF07714; Pkinase_Tyr; 1.\n",
        "DR   Pfam; PF02196; RBD; 1.\n",
        "DR   PRINTS; PR00008; DAGPEDOMAIN.\n",
        "DR   SMART; SM00109; C1; 1.\n",
        "DR   SMART; SM00455; RBD; 1.\n",
        "DR   SUPFAM; SSF54236; SSF54236; 1.\n",
        "DR   SUPFAM; SSF56112; SSF56112; 1.\n",
        "DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.\n",
        "DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.\n",
        "DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.\n",
        "DR   PROSITE; PS50898; RBD; 1.\n",
        "DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.\n",
        "DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.\n",
        "PE   1: Evidence at protein level;\n",
        "KW   3D-structure; Acetylation; ATP-binding; Cardiomyopathy; Cell membrane;\n",
        "KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Deafness;\n",
        "KW   Direct protein sequencing; Disease mutation; Ectodermal dysplasia;\n",
        "KW   Isopeptide bond; Kinase; Membrane; Mental retardation; Metal-binding;\n",
        "KW   Methylation; Nucleotide-binding; Nucleus; Phosphoprotein;\n",
        "KW   Polymorphism; Proto-oncogene; Reference proteome;\n",
        "KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation; Zinc;\n",
        "KW   Zinc-finger.\n",
        "FT   INIT_MET      1      1       Removed.\n",
        "FT   CHAIN         2    766       Serine/threonine-protein kinase B-raf.\n",
        "FT                                /FTId=PRO_0000085665.\n",
        "FT   DOMAIN      155    227       RBD.\n",
        "FT   DOMAIN      457    717       Protein kinase.\n",
        "FT   ZN_FING     234    280       Phorbol-ester/DAG-type.\n",
        "FT   NP_BIND     463    471       ATP (By similarity).\n",
        "FT   COMPBIAS      6     11       Poly-Gly.\n",
        "FT   COMPBIAS    122    129       Poly-Ser.\n",
        "FT   COMPBIAS    428    432       Poly-Ser.\n",
        "FT   ACT_SITE    576    576       Proton acceptor (By similarity).\n",
        "FT   METAL       235    235       Zinc 1 (By similarity).\n",
        "FT   METAL       248    248       Zinc 2 (By similarity).\n",
        "FT   METAL       251    251       Zinc 2 (By similarity).\n",
        "FT   METAL       261    261       Zinc 1 (By similarity).\n",
        "FT   METAL       264    264       Zinc 1 (By similarity).\n",
        "FT   METAL       269    269       Zinc 2 (By similarity).\n",
        "FT   METAL       272    272       Zinc 2 (By similarity).\n",
        "FT   METAL       280    280       Zinc 1 (By similarity).\n",
        "FT   BINDING     483    483       ATP (By similarity).\n",
        "FT   SITE        380    381       Breakpoint for translocation to form\n",
        "FT                                KIAA1549-BRAF fusion protein.\n",
        "FT   SITE        438    439       Breakpoint for translocation to form\n",
        "FT                                KIAA1549-BRAF fusion protein.\n",
        "FT   MOD_RES       2      2       N-acetylalanine.\n",
        "FT   MOD_RES     365    365       Phosphoserine; by SGK1.\n",
        "FT   MOD_RES     373    373       Phosphothreonine; by autocatalysis.\n",
        "FT   MOD_RES     396    396       Phosphothreonine.\n",
        "FT   MOD_RES     399    399       Phosphoserine.\n",
        "FT   MOD_RES     401    401       Phosphothreonine.\n",
        "FT   MOD_RES     446    446       Phosphoserine.\n",
        "FT   MOD_RES     447    447       Phosphoserine.\n",
        "FT   MOD_RES     671    671       Omega-N-methylarginine; by PRMT5.\n",
        "FT   MOD_RES     729    729       Phosphoserine.\n",
        "FT   MOD_RES     753    753       Phosphothreonine; by MAPK1.\n",
        "FT   CROSSLNK    578    578       Glycyl lysine isopeptide (Lys-Gly)\n",
        "FT                                (interchain with G-Cter in ubiquitin).\n",
        "FT   VARIANT     241    241       T -> M (in a patient with Noonan\n",
        "FT                                syndrome).\n",
        "FT                                /FTId=VAR_058620.\n",
        "FT   VARIANT     241    241       T -> P (in CFC1 and LEOPARD3).\n",
        "FT                                /FTId=VAR_058621.\n",
        "FT   VARIANT     241    241       T -> R (in a patient with Noonan\n",
        "FT                                syndrome).\n",
        "FT                                /FTId=VAR_058622.\n",
        "FT   VARIANT     244    244       T -> P (in CFC1).\n",
        "FT                                /FTId=VAR_065171.\n",
        "FT   VARIANT     245    245       L -> F (in CFC1).\n",
        "FT                                /FTId=VAR_058623.\n",
        "FT   VARIANT     246    246       A -> P (in CFC1).\n",
        "FT                                /FTId=VAR_026113.\n",
        "FT   VARIANT     257    257       Q -> R (in CFC1).\n",
        "FT                                /FTId=VAR_026114.\n",
        "FT   VARIANT     262    262       Q -> K (in CFC1).\n",
        "FT                                /FTId=VAR_065172.\n",
        "FT   VARIANT     275    275       E -> K (in CFC1).\n",
        "FT                                /FTId=VAR_058624.\n",
        "FT   VARIANT     301    301       P -> S (in dbSNP:rs34776339).\n",
        "FT                                /FTId=VAR_040391.\n",
        "FT   VARIANT     462    462       R -> I (in CRC).\n",
        "FT                                /FTId=VAR_018613.\n",
        "FT   VARIANT     463    463       I -> S (in CRC).\n",
        "FT                                /FTId=VAR_018614.\n",
        "FT   VARIANT     464    464       G -> E (in CRC).\n",
        "FT                                /FTId=VAR_018615.\n",
        "FT   VARIANT     464    464       G -> V (in a colorectal cancer cell line;\n",
        "FT                                elevated kinase activity; efficiently\n",
        "FT                                induces cell transformation).\n",
        "FT                                /FTId=VAR_018616.\n",
        "FT   VARIANT     466    466       G -> A (in melanoma).\n",
        "FT                                /FTId=VAR_018617.\n",
        "FT   VARIANT     466    466       G -> E (in melanoma).\n",
        "FT                                /FTId=VAR_018618.\n",
        "FT   VARIANT     466    466       G -> V (in LNCR).\n",
        "FT                                /FTId=VAR_018512.\n",
        "FT   VARIANT     467    467       S -> A (in CFC1).\n",
        "FT                                /FTId=VAR_035096.\n",
        "FT   VARIANT     468    468       F -> S (in CFC1).\n",
        "FT                                /FTId=VAR_035097.\n",
        "FT   VARIANT     469    469       G -> A (in NHL; also in a lung\n",
        "FT                                adenocarcinoma sample; somatic mutation;\n",
        "FT                                elevated kinase activity; efficiently\n",
        "FT                                induces cell transformation).\n",
        "FT                                /FTId=VAR_018620.\n",
        "FT   VARIANT     469    469       G -> E (in CFC1 and colon cancer).\n",
        "FT                                /FTId=VAR_018621.\n",
        "FT   VARIANT     469    469       G -> R (in NHL).\n",
        "FT                                /FTId=VAR_018622.\n",
        "FT   VARIANT     469    469       G -> V (in a colorectal adenocarcinoma\n",
        "FT                                sample; somatic mutation).\n",
        "FT                                /FTId=VAR_040392.\n",
        "FT   VARIANT     485    485       L -> F (in CFC1).\n",
        "FT                                /FTId=VAR_026115.\n",
        "FT   VARIANT     499    499       K -> E (in CFC1).\n",
        "FT                                /FTId=VAR_026116.\n",
        "FT   VARIANT     499    499       K -> N (in CFC1).\n",
        "FT                                /FTId=VAR_058625.\n",
        "FT   VARIANT     501    501       E -> G (in CFC1).\n",
        "FT                                /FTId=VAR_026117.\n",
        "FT   VARIANT     501    501       E -> K (in CFC1).\n",
        "FT                                /FTId=VAR_026118.\n",
        "FT   VARIANT     525    525       L -> P (in CFC1).\n",
        "FT                                /FTId=VAR_058626.\n",
        "FT   VARIANT     531    531       W -> C (in NS7).\n",
        "FT                                /FTId=VAR_058627.\n",
        "FT   VARIANT     580    580       N -> D (in CFC1).\n",
        "FT                                /FTId=VAR_065173.\n",
        "FT   VARIANT     581    581       N -> D (in CFC1).\n",
        "FT                                /FTId=VAR_026119.\n",
        "FT   VARIANT     581    581       N -> S (in a colorectal adenocarcinoma\n",
        "FT                                sample; somatic mutation).\n",
        "FT                                /FTId=VAR_040393.\n",
        "FT   VARIANT     586    586       E -> K (in ovarian cancer).\n",
        "FT                                /FTId=VAR_018623.\n",
        "FT   VARIANT     594    594       D -> G (in NHL).\n",
        "FT                                /FTId=VAR_018624.\n",
        "FT   VARIANT     595    595       F -> L (in colon cancer and CFC1).\n",
        "FT                                /FTId=VAR_018625.\n",
        "FT   VARIANT     596    596       G -> R (in a colorectal adenocarcinoma\n",
        "FT                                sample; somatic mutation).\n",
        "FT                                /FTId=VAR_018626.\n",
        "FT   VARIANT     596    596       G -> V (in CFC1).\n",
        "FT                                /FTId=VAR_035098.\n",
        "FT   VARIANT     597    597       L -> R (in LNCR; also found in an ovarian\n",
        "FT                                serous carcinoma sample; somatic\n",
        "FT                                mutation).\n",
        "FT                                /FTId=VAR_018513.\n",
        "FT   VARIANT     597    597       L -> V (in NS7; also in a lung\n",
        "FT                                adenocarcinoma sample; somatic mutation;\n",
        "FT                                elevated kinase activity; efficiently\n",
        "FT                                induces cell transformation).\n",
        "FT                                /FTId=VAR_018627.\n",
        "FT   VARIANT     599    599       T -> R (in CFC1).\n",
        "FT                                /FTId=VAR_058628.\n",
        "FT   VARIANT     600    600       V -> D (in a melanoma cell line; requires\n",
        "FT                                2 nucleotide substitutions).\n",
        "FT                                /FTId=VAR_018628.\n",
        "FT   VARIANT     600    600       V -> E (in CRC; also found in sarcoma,\n",
        "FT                                metastatic melanoma, ovarian serous\n",
        "FT                                carcinoma, pilocytic astrocytoma; somatic\n",
        "FT                                mutation; most common mutation;\n",
        "FT                                constitutive and elevated kinase\n",
        "FT                                activity; efficiently induces cell\n",
        "FT                                transformation; suppression of mutation\n",
        "FT                                in melanoma causes growth arrest and\n",
        "FT                                promotes apoptosis; loss of regulation by\n",
        "FT                                PMRT5).\n",
        "FT                                /FTId=VAR_018629.\n",
        "FT   VARIANT     601    601       K -> E (in CRC).\n",
        "FT                                /FTId=VAR_018630.\n",
        "FT   VARIANT     601    601       K -> Q (in CFC1).\n",
        "FT                                /FTId=VAR_058629.\n",
        "FT   VARIANT     638    638       D -> E (in CFC1).\n",
        "FT                                /FTId=VAR_058630.\n",
        "FT   VARIANT     709    709       Q -> R (in CFC1).\n",
        "FT                                /FTId=VAR_058631.\n",
        "FT   MUTAGEN     483    483       K->S: Reduces kinase activity with\n",
        "FT                                MAP2K1.\n",
        "FT   MUTAGEN     578    578       K->R: Blocks EGF-induced ubiquitination\n",
        "FT                                and ERK activation.\n",
        "FT   MUTAGEN     671    671       R->K: Increased kinase activity and\n",
        "FT                                stability in response to EGF treatment.\n",
        "FT   CONFLICT    766    766       H -> D (in Ref. 11; AAA96495).\n",
        "FT   STRAND      156    161\n",
        "FT   TURN        162    164\n",
        "FT   STRAND      165    170\n",
        "FT   HELIX       177    186\n",
        "FT   TURN        187    189\n",
        "FT   HELIX       192    194\n",
        "FT   STRAND      195    199\n",
        "FT   STRAND      206    208\n",
        "FT   HELIX       214    217\n",
        "FT   STRAND      221    226\n",
        "FT   STRAND      458    465\n",
        "FT   STRAND      467    486\n",
        "FT   STRAND      487    489\n",
        "FT   HELIX       492    505\n",
        "FT   STRAND      516    520\n",
        "FT   STRAND      522    524\n",
        "FT   STRAND      526    530\n",
        "FT   STRAND      534    536\n",
        "FT   HELIX       537    541\n",
        "FT   TURN        542    544\n",
        "FT   HELIX       550    569\n",
        "FT   STRAND      581    585\n",
        "FT   TURN        586    588\n",
        "FT   STRAND      589    592\n",
        "FT   STRAND      599    601\n",
        "FT   HELIX       617    619\n",
        "FT   HELIX       622    625\n",
        "FT   STRAND      629    631\n",
        "FT   HELIX       635    651\n",
        "FT   TURN        655    658\n",
        "FT   HELIX       662    670\n",
        "FT   HELIX       678    680\n",
        "FT   STRAND      683    685\n",
        "FT   HELIX       687    696\n",
        "FT   HELIX       701    703\n",
        "FT   HELIX       707    716\n",
        "FT   HELIX       718    720\n",
        "SQ   SEQUENCE   766 AA;  84437 MW;  0798C2AAB487E813 CRC64;\n",
        "     MAALSGGGGG GAEPGQALFN GDMEPEAGAG AGAAASSAAD PAIPEEVWNI KQMIKLTQEH\n",
        "     IEALLDKFGG EHNPPSIYLE AYEEYTSKLD ALQQREQQLL ESLGNGTDFS VSSSASMDTV\n",
        "     TSSSSSSLSV LPSSLSVFQN PTDVARSNPK SPQKPIVRVF LPNKQRTVVP ARCGVTVRDS\n",
        "     LKKALMMRGL IPECCAVYRI QDGEKKPIGW DTDISWLTGE ELHVEVLENV PLTTHNFVRK\n",
        "     TFFTLAFCDF CRKLLFQGFR CQTCGYKFHQ RCSTEVPLMC VNYDQLDLLF VSKFFEHHPI\n",
        "     PQEEASLAET ALTSGSSPSA PASDSIGPQI LTSPSPSKSI PIPQPFRPAD EDHRNQFGQR\n",
        "     DRSSSAPNVH INTIEPVNID DLIRDQGFRG DGGSTTGLSA TPPASLPGSL TNVKALQKSP\n",
        "     GPQRERKSSS SSEDRNRMKT LGRRDSSDDW EIPDGQITVG QRIGSGSFGT VYKGKWHGDV\n",
        "     AVKMLNVTAP TPQQLQAFKN EVGVLRKTRH VNILLFMGYS TKPQLAIVTQ WCEGSSLYHH\n",
        "     LHIIETKFEM IKLIDIARQT AQGMDYLHAK SIIHRDLKSN NIFLHEDLTV KIGDFGLATV\n",
        "     KSRWSGSHQF EQLSGSILWM APEVIRMQDK NPYSFQSDVY AFGIVLYELM TGQLPYSNIN\n",
        "     NRDQIIFMVG RGYLSPDLSK VRSNCPKAMK RLMAECLKKK RDERPLFPQI LASIELLARS\n",
        "     LPKIHRSASE PSLNRAGFQT EDFSLYACAS PKTPIQAGGY GAFPVH\n",
        "//\n",
        "ID   RASK_HUMAN              Reviewed;         189 AA.\n",
        "AC   P01116; A8K8Z5; B0LPF9; P01118; Q96D10;\n",
        "DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.\n",
        "DT   21-JUL-1986, sequence version 1.\n",
        "DT   09-JUL-2014, entry version 178.\n",
        "DE   RecName: Full=GTPase KRas;\n",
        "DE   AltName: Full=K-Ras 2;\n",
        "DE   AltName: Full=Ki-Ras;\n",
        "DE   AltName: Full=c-K-ras;\n",
        "DE   AltName: Full=c-Ki-ras;\n",
        "DE   Contains:\n",
        "DE     RecName: Full=GTPase KRas, N-terminally processed;\n",
        "DE   Flags: Precursor;\n",
        "GN   Name=KRAS; Synonyms=KRAS2, RASK2;\n",
        "OS   Homo sapiens (Human).\n",
        "OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
        "OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
        "OC   Catarrhini; Hominidae; Homo.\n",
        "OX   NCBI_TaxID=9606;\n",
        "RN   [1]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2A AND 2B).\n",
        "RX   PubMed=6308466; DOI=10.1038/304501a0;\n",
        "RA   McGrath J.P., Capon D.J., Smith D.H., Chen E.Y., Seeburg P.H.,\n",
        "RA   Goeddel D.V., Levinson A.D.;\n",
        "RT   \"Structure and organization of the human Ki-ras proto-oncogene and a\n",
        "RT   related processed pseudogene.\";\n",
        "RL   Nature 304:501-506(1983).\n",
        "RN   [2]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2A AND 2B).\n",
        "RC   TISSUE=Lung carcinoma;\n",
        "RX   PubMed=6308465; DOI=10.1038/304497a0;\n",
        "RA   Shimizu K., Birnbaum D., Ruley M.A., Fasano O., Suard Y., Edlund L.,\n",
        "RA   Taparowsky E., Goldfarb M., Wigler M.;\n",
        "RT   \"Structure of the Ki-ras gene of the human lung carcinoma cell line\n",
        "RT   Calu-1.\";\n",
        "RL   Nature 304:497-500(1983).\n",
        "RN   [3]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2A AND 2B).\n",
        "RC   TISSUE=Colon carcinoma, and Lung;\n",
        "RX   PubMed=6308467; DOI=10.1038/304507a0;\n",
        "RA   Capon D.J., Seeburg P.H., McGrath J.P., Hayflick J.S., Edman U.,\n",
        "RA   Levinson A.D., Goeddel D.V.;\n",
        "RT   \"Activation of Ki-ras2 gene in human colon and lung carcinomas by two\n",
        "RT   different point mutations.\";\n",
        "RL   Nature 304:507-513(1983).\n",
        "RN   [4]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2A AND 2B), AND VARIANT\n",
        "RP   COLON CANCER VAL-12.\n",
        "RC   TISSUE=Colon carcinoma;\n",
        "RX   PubMed=6092920;\n",
        "RA   McCoy M.S., Bargmann C.I., Weinberg R.A.;\n",
        "RT   \"Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-\n",
        "RT   oncogene.\";\n",
        "RL   Mol. Cell. Biol. 4:1577-1582(1984).\n",
        "RN   [5]\n",
        "RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2B).\n",
        "RX   PubMed=3310850;\n",
        "RA   Kahn S., Yamamoto F., Almoguera C., Winter E., Forrester K.,\n",
        "RA   Jordano J., Perucho M.;\n",
        "RT   \"The c-K-ras gene and human cancer (review).\";\n",
        "RL   Anticancer Res. 7:639-652(1987).\n",
        "RN   [6]\n",
        "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2B).\n",
        "RC   TISSUE=Brain;\n",
        "RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;\n",
        "RT   \"cDNA clones of human proteins involved in signal transduction\n",
        "RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).\";\n",
        "RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.\n",
        "RN   [7]\n",
        "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2B), AND VARIANT LUNG\n",
        "RP   CARCINOMA HIS-61.\n",
        "RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,\n",
        "RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,\n",
        "RA   Phelan M., Farmer A.;\n",
        "RT   \"Cloning of human full-length CDSs in BD Creator(TM) system donor\n",
        "RT   vector.\";\n",
        "RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.\n",
        "RN   [8]\n",
        "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2B).\n",
        "RC   TISSUE=Testis;\n",
        "RX   PubMed=14702039; DOI=10.1038/ng1285;\n",
        "RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,\n",
        "RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,\n",
        "RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,\n",
        "RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,\n",
        "RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,\n",
        "RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,\n",
        "RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,\n",
        "RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,\n",
        "RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,\n",
        "RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,\n",
        "RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,\n",
        "RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,\n",
        "RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,\n",
        "RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,\n",
        "RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,\n",
        "RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,\n",
        "RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,\n",
        "RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,\n",
        "RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,\n",
        "RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,\n",
        "RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,\n",
        "RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,\n",
        "RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,\n",
        "RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,\n",
        "RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,\n",
        "RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,\n",
        "RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,\n",
        "RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;\n",
        "RT   \"Complete sequencing and characterization of 21,243 full-length human\n",
        "RT   cDNAs.\";\n",
        "RL   Nat. Genet. 36:40-45(2004).\n",
        "RN   [9]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\n",
        "RG   SeattleSNPs variation discovery resource;\n",
        "RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.\n",
        "RN   [10]\n",
        "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\n",
        "RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,\n",
        "RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,\n",
        "RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,\n",
        "RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,\n",
        "RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,\n",
        "RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,\n",
        "RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,\n",
        "RA   Venter J.C.;\n",
        "RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.\n",
        "RN   [11]\n",
        "RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2B), AND VARIANT LUNG\n",
        "RP   CARCINOMA HIS-61.\n",
        "RC   TISSUE=Lung carcinoma;\n",
        "RX   PubMed=15489334; DOI=10.1101/gr.2596504;\n",
        "RG   The MGC Project Team;\n",
        "RT   \"The status, quality, and expansion of the NIH full-length cDNA\n",
        "RT   project: the Mammalian Gene Collection (MGC).\";\n",
        "RL   Genome Res. 14:2121-2127(2004).\n",
        "RN   [12]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-37, AND VARIANT LUNG CARCINOMA\n",
        "RP   CYS-12.\n",
        "RC   TISSUE=Lung carcinoma;\n",
        "RX   PubMed=6320174; DOI=10.1073/pnas.81.1.71;\n",
        "RA   Nakano H., Yamamoto F., Neville C., Evans D., Mizuno T., Perucho M.;\n",
        "RT   \"Isolation of transforming sequences of two human lung carcinomas:\n",
        "RT   structural and functional analysis of the activated c-K-ras\n",
        "RT   oncogenes.\";\n",
        "RL   Proc. Natl. Acad. Sci. U.S.A. 81:71-75(1984).\n",
        "RN   [13]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-96.\n",
        "RC   TISSUE=Pancreatic carcinoma;\n",
        "RX   PubMed=3855240; DOI=10.1016/S0006-291X(85)80140-6;\n",
        "RA   Hirai H., Okabe T., Anraku Y., Fujisawa M., Urabe A., Takaku F.;\n",
        "RT   \"Activation of the c-K-ras oncogene in a human pancreas carcinoma.\";\n",
        "RL   Biochem. Biophys. Res. Commun. 127:168-174(1985).\n",
        "RN   [14]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-37, AND VARIANT GASC VAL-12.\n",
        "RX   PubMed=3034404;\n",
        "RA   Deng G., Lu Y., Chen S., Miao J., Lu G., Li H., Cai H., Xu X.,\n",
        "RA   Zheng E., Liu P.;\n",
        "RT   \"Activated c-Ha-ras oncogene with a guanine to thymine transversion at\n",
        "RT   the twelfth codon in a human stomach cancer cell line.\";\n",
        "RL   Cancer Res. 47:3195-3198(1987).\n",
        "RN   [15]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-36, AND VARIANT BLADDER/LUNG\n",
        "RP   CANCER ARG-12.\n",
        "RC   TISSUE=Lung carcinoma;\n",
        "RX   PubMed=6695174; DOI=10.1126/science.6695174;\n",
        "RA   Santos E., Martin-Zanca D., Reddy P.E., Pierotti M.A., Porta G.,\n",
        "RA   Barbacid M.;\n",
        "RT   \"Malignant activation of a K-ras oncogene in lung carcinoma but not in\n",
        "RT   normal tissue of the same patient.\";\n",
        "RL   Science 223:661-664(1984).\n",
        "RN   [16]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-37.\n",
        "RX   PubMed=3932274;\n",
        "RA   Sekiya T., Tokunaga A., Fushimi M.;\n",
        "RT   \"Essential region for transforming activity of human c-Ha-ras-1.\";\n",
        "RL   Jpn. J. Cancer Res. 76:787-791(1985).\n",
        "RN   [17]\n",
        "RP   PROTEIN SEQUENCE OF 1-41; 43-147 AND 150-161, CLEAVAGE OF INITIATOR\n",
        "RP   METHIONINE, ACETYLATION AT MET-1 AND THR-2, AND IDENTIFICATION BY MASS\n",
        "RP   SPECTROMETRY.\n",
        "RC   TISSUE=Cervix carcinoma;\n",
        "RA   Bienvenut W.V., Calvo F., Kolch W.;\n",
        "RL   Submitted (FEB-2008) to UniProtKB.\n",
        "RN   [18]\n",
        "RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 38-96.\n",
        "RC   TISSUE=Lung carcinoma;\n",
        "RX   PubMed=6096811; DOI=10.1093/nar/12.23.8873;\n",
        "RA   Yamamoto F., Perucho M.;\n",
        "RT   \"Activation of a human c-K-ras oncogene.\";\n",
        "RL   Nucleic Acids Res. 12:8873-8885(1984).\n",
        "RN   [19]\n",
        "RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\n",
        "RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;\n",
        "RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,\n",
        "RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;\n",
        "RT   \"Initial characterization of the human central proteome.\";\n",
        "RL   BMC Syst. Biol. 5:17-17(2011).\n",
        "RN   [20]\n",
        "RP   ACETYLATION AT LYS-104, AND VARIANT VAL-12.\n",
        "RX   PubMed=22711838; DOI=10.1073/pnas.1201487109;\n",
        "RA   Yang M.H., Nickerson S., Kim E.T., Liot C., Laurent G., Spang R.,\n",
        "RA   Philips M.R., Shan Y., Shaw D.E., Bar-Sagi D., Haigis M.C.,\n",
        "RA   Haigis K.M.;\n",
        "RT   \"Regulation of RAS oncogenicity by acetylation.\";\n",
        "RL   Proc. Natl. Acad. Sci. U.S.A. 109:10843-10848(2012).\n",
        "RN   [21]\n",
        "RP   VARIANT BREAST CANCER ASP-13.\n",
        "RX   PubMed=3627975; DOI=10.1093/nar/15.15.5963;\n",
        "RA   Kozma S.C., Bogaard M.E., Buser K., Saurer S.M., Bos J.L., Groner B.,\n",
        "RA   Hynes N.E.;\n",
        "RT   \"The human c-Kirsten ras gene is activated by a novel mutation in\n",
        "RT   codon 13 in the breast carcinoma cell line MDA-MB231.\";\n",
        "RL   Nucleic Acids Res. 15:5963-5971(1987).\n",
        "RN   [22]\n",
        "RP   VARIANT BLADDER CANCER THR-59.\n",
        "RX   PubMed=1553789; DOI=10.1007/BF00296523;\n",
        "RA   Grimmond S.M., Raghavan D., Russell P.J.;\n",
        "RT   \"Detection of a rare point mutation in Ki-ras of a human bladder\n",
        "RT   cancer xenograft by polymerase chain reaction and direct sequencing.\";\n",
        "RL   Urol. Res. 20:121-126(1992).\n",
        "RN   [23]\n",
        "RP   VARIANTS PANCREATIC CARCINOMA ASP-12 AND VAL-12.\n",
        "RX   PubMed=8439212; DOI=10.1097/00000658-199302000-00007;\n",
        "RA   Motojima K., Urano T., Nagata Y., Shiku H., Tsurifune T.,\n",
        "RA   Kanematsu T.;\n",
        "RT   \"Detection of point mutations in the Kirsten-ras oncogene provides\n",
        "RT   evidence for the multicentricity of pancreatic carcinoma.\";\n",
        "RL   Ann. Surg. 217:138-143(1993).\n",
        "RN   [24]\n",
        "RP   VARIANTS GASC SER-12 AND ASP-12.\n",
        "RX   PubMed=7773929;\n",
        "RX   DOI=10.1002/1097-0142(19950615)75:12<2794::AID-CNCR2820751203>3.0.CO;2-F;\n",
        "RA   Lee K.H., Lee J.S., Suh C., Kim S.W., Kim S.B., Lee J.H., Lee M.S.,\n",
        "RA   Park M.Y., Sun H.S., Kim S.H.;\n",
        "RT   \"Clinicopathologic significance of the K-ras gene codon 12 point\n",
        "RT   mutation in stomach cancer. An analysis of 140 cases.\";\n",
        "RL   Cancer 75:2794-2801(1995).\n",
        "RN   [25]\n",
        "RP   INVOLVEMENT IN AML, VARIANT GLY-10 INS, AND CHARACTERIZATION OF\n",
        "RP   VARIANT GLY-10 INS.\n",
        "RX   PubMed=8955068; DOI=10.1074/jbc.271.51.32491;\n",
        "RA   Bollag G., Adler F., elMasry N., McCabe P.C., Conner E. Jr.,\n",
        "RA   Thompson P., McCormick F., Shannon K.;\n",
        "RT   \"Biochemical characterization of a novel KRAS insertion mutation from\n",
        "RT   a human leukemia.\";\n",
        "RL   J. Biol. Chem. 271:32491-32494(1996).\n",
        "RN   [26]\n",
        "RP   VARIANTS GASC ASN-5; VAL-12; ASP-13 AND THR-59.\n",
        "RX   PubMed=14534542; DOI=10.1038/sj.onc.1206749;\n",
        "RA   Lee S.H., Lee J.W., Soung Y.H., Kim H.S., Park W.S., Kim S.Y.,\n",
        "RA   Lee J.H., Park J.Y., Cho Y.G., Kim C.J., Nam S.W., Kim S.H., Lee J.Y.,\n",
        "RA   Yoo N.J.;\n",
        "RT   \"BRAF and KRAS mutations in stomach cancer.\";\n",
        "RL   Oncogene 22:6942-6945(2003).\n",
        "RN   [27]\n",
        "RP   VARIANT PYLOCYTIC ASTROCYTOMA ARG-13.\n",
        "RX   PubMed=16247081; DOI=10.1212/01.wnl.0000180409.78098.d7;\n",
        "RA   Sharma M.K., Zehnbauer B.A., Watson M.A., Gutmann D.H.;\n",
        "RT   \"RAS pathway activation and an oncogenic RAS mutation in sporadic\n",
        "RT   pilocytic astrocytoma.\";\n",
        "RL   Neurology 65:1335-1336(2005).\n",
        "RN   [28]\n",
        "RP   VARIANTS NS3 GLY-152 (ISOSORM 2) AND VAL-153 (ISOFORM 2).\n",
        "RX   PubMed=16773572; DOI=10.1086/504394;\n",
        "RA   Carta C., Pantaleoni F., Bocchinfuso G., Stella L., Vasta I.,\n",
        "RA   Sarkozy A., Digilio C., Palleschi A., Pizzuti A., Grammatico P.,\n",
        "RA   Zampino G., Dallapiccola B., Gelb B.D., Tartaglia M.;\n",
        "RT   \"Germline missense mutations affecting KRAS Isoform B are associated\n",
        "RT   with a severe Noonan syndrome phenotype.\";\n",
        "RL   Am. J. Hum. Genet. 79:129-135(2006).\n",
        "RN   [29]\n",
        "RP   VARIANTS LUNG CARCINOMA CYS-12; ASP-12; SER-12; VAL-12 AND HIS-61.\n",
        "RX   PubMed=16533793; DOI=10.1158/1078-0432.CCR-05-1981;\n",
        "RA   Tam I.Y.S., Chung L.P., Suen W.S., Wang E., Wong M.C.M., Ho K.K.,\n",
        "RA   Lam W.K., Chiu S.W., Girard L., Minna J.D., Gazdar A.F., Wong M.P.;\n",
        "RT   \"Distinct epidermal growth factor receptor and KRAS mutation patterns\n",
        "RT   in non-small cell lung cancer patients with different tobacco exposure\n",
        "RT   and clinicopathologic features.\";\n",
        "RL   Clin. Cancer Res. 12:1647-1653(2006).\n",
        "RN   [30]\n",
        "RP   VARIANT CFC2 ARG-60.\n",
        "RX   PubMed=16474404; DOI=10.1038/ng1749;\n",
        "RA   Niihori T., Aoki Y., Narumi Y., Neri G., Cave H., Verloes A.,\n",
        "RA   Okamoto N., Hennekam R.C.M., Gillessen-Kaesbach G., Wieczorek D.,\n",
        "RA   Kavamura M.I., Kurosawa K., Ohashi H., Wilson L., Heron D.,\n",
        "RA   Bonneau D., Corona G., Kaname T., Naritomi K., Baumann C.,\n",
        "RA   Matsumoto N., Kato K., Kure S., Matsubara Y.;\n",
        "RT   \"Germline KRAS and BRAF mutations in cardio-facio-cutaneous\n",
        "RT   syndrome.\";\n",
        "RL   Nat. Genet. 38:294-296(2006).\n",
        "RN   [31]\n",
        "RP   VARIANTS NS3 ILE-14 AND ILE-58, VARIANT CFC2 ARG-34, AND\n",
        "RP   CHARACTERIZATION OF VARIANTS NS3 ILE-14 AND ILE-58.\n",
        "RX   PubMed=16474405; DOI=10.1038/ng1748;\n",
        "RA   Schubbert S., Zenker M., Rowe S.L., Boell S., Klein C., Bollag G.,\n",
        "RA   van der Burgt I., Musante L., Kalscheuer V., Wehner L.-E., Nguyen H.,\n",
        "RA   West B., Zhang K.Y.J., Sistermans E., Rauch A., Niemeyer C.M.,\n",
        "RA   Shannon K., Kratz C.P.;\n",
        "RT   \"Germline KRAS mutations cause Noonan syndrome.\";\n",
        "RL   Nat. Genet. 38:331-336(2006).\n",
        "RN   [32]\n",
        "RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-12; ASP-12; SER-12; VAL-12;\n",
        "RP   ASP-13; ARG-61; ASN-117 AND THR-146.\n",
        "RX   PubMed=16959974; DOI=10.1126/science.1133427;\n",
        "RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,\n",
        "RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,\n",
        "RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,\n",
        "RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,\n",
        "RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,\n",
        "RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;\n",
        "RT   \"The consensus coding sequences of human breast and colorectal\n",
        "RT   cancers.\";\n",
        "RL   Science 314:268-274(2006).\n",
        "RN   [33]\n",
        "RP   VARIANT NS3 GLU-5.\n",
        "RX   PubMed=17468812; DOI=10.1007/s10038-007-0146-1;\n",
        "RA   Bertola D.R., Pereira A.C., Brasil A.S., Albano L.M., Kim C.A.,\n",
        "RA   Krieger J.E.;\n",
        "RT   \"Further evidence of genetic heterogeneity in Costello syndrome:\n",
        "RT   involvement of the KRAS gene.\";\n",
        "RL   J. Hum. Genet. 52:521-526(2007).\n",
        "RN   [34]\n",
        "RP   VARIANTS NS3 ILE-14; ARG-22; LEU-34; GLN-34; MET-36 AND VAL-153\n",
        "RP   (ISOFORM 2), VARIANT CFC2 GLU-22, VARIANT NS3/CFC2 ILE-156 (ISOFORM\n",
        "RP   2), AND VARIANTS ASN-5 AND LEU-156 (ISOFORM 2).\n",
        "RX   PubMed=17056636; DOI=10.1136/jmg.2006.046300;\n",
        "RA   Zenker M., Lehmann K., Schulz A.L., Barth H., Hansmann D., Koenig R.,\n",
        "RA   Korinthenberg R., Kreiss-Nachtsheim M., Meinecke P., Morlot S.,\n",
        "RA   Mundlos S., Quante A.S., Raskin S., Schnabel D., Wehner L.E.,\n",
        "RA   Kratz C.P., Horn D., Kutsche K.;\n",
        "RT   \"Expansion of the genotypic and phenotypic spectrum in patients with\n",
        "RT   KRAS germline mutations.\";\n",
        "RL   J. Med. Genet. 44:131-135(2007).\n",
        "RN   [35]\n",
        "RP   VARIANTS NS3 ILE-58 AND SER-60.\n",
        "RX   PubMed=19396835; DOI=10.1002/ajmg.a.32786;\n",
        "RA   Kratz C.P., Zampino G., Kriek M., Kant S.G., Leoni C., Pantaleoni F.,\n",
        "RA   Oudesluys-Murphy A.M., Di Rocco C., Kloska S.P., Tartaglia M.,\n",
        "RA   Zenker M.;\n",
        "RT   \"Craniosynostosis in patients with Noonan syndrome caused by germline\n",
        "RT   KRAS mutations.\";\n",
        "RL   Am. J. Med. Genet. A 149:1036-1040(2009).\n",
        "RN   [36]\n",
        "RP   CHARACTERIZATION OF VARIANTS NS3 ILE-14; ARG-22; LEU-34; ILE-58 AND\n",
        "RP   VAL-153 (ISOFORM 2), CHARACTERIZATION OF VARIANTS CFC2 GLU-22; ARG-34\n",
        "RP   AND ARG-60, AND CHARACTERIZATION OF VARIANTS ASN-5 AND LEU-156\n",
        "RP   (ISOFORM 2).\n",
        "RX   PubMed=20949621; DOI=10.1002/humu.21377;\n",
        "RA   Gremer L., Merbitz-Zahradnik T., Dvorsky R., Cirstea I.C., Kratz C.P.,\n",
        "RA   Zenker M., Wittinghofer A., Ahmadian M.R.;\n",
        "RT   \"Germline KRAS mutations cause aberrant biochemical and physical\n",
        "RT   properties leading to developmental disorders.\";\n",
        "RL   Hum. Mutat. 32:33-43(2011).\n",
        "RN   [37]\n",
        "RP   VARIANTS CFC2 HIS-71 AND GLU-147.\n",
        "RX   PubMed=21797849; DOI=10.1111/j.1399-0004.2011.01754.x;\n",
        "RA   Stark Z., Gillessen-Kaesbach G., Ryan M.M., Cirstea I.C., Gremer L.,\n",
        "RA   Ahmadian M.R., Savarirayan R., Zenker M.;\n",
        "RT   \"Two novel germline KRAS mutations: expanding the molecular and\n",
        "RT   clinical phenotype.\";\n",
        "RL   Clin. Genet. 81:590-594(2012).\n",
        "CC   -!- FUNCTION: Ras proteins bind GDP/GTP and possess intrinsic GTPase\n",
        "CC       activity.\n",
        "CC   -!- ENZYME REGULATION: Alternates between an inactive form bound to\n",
        "CC       GDP and an active form bound to GTP. Activated by a guanine\n",
        "CC       nucleotide-exchange factor (GEF) and inactivated by a GTPase-\n",
        "CC       activating protein (GAP).\n",
        "CC   -!- SUBUNIT: Interacts with PHLPP. Interacts (active GTP-bound form\n",
        "CC       preferentially) with RGS14 (By similarity).\n",
        "CC   -!- INTERACTION:\n",
        "CC       Q04631:Fnta (xeno); NbExp=2; IntAct=EBI-367427, EBI-602447;\n",
        "CC       P04049:RAF1; NbExp=2; IntAct=EBI-367427, EBI-365996;\n",
        "CC       P50749:RASSF2; NbExp=2; IntAct=EBI-367415, EBI-960081;\n",
        "CC   -!- SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic\n",
        "CC       side.\n",
        "CC   -!- ALTERNATIVE PRODUCTS:\n",
        "CC       Event=Alternative splicing; Named isoforms=2;\n",
        "CC         Comment=Isoforms differ in the C-terminal region which is\n",
        "CC         encoded by two alternative exons (IVA and IVB);\n",
        "CC       Name=2A; Synonyms=K-Ras4A;\n",
        "CC         IsoId=P01116-1; Sequence=Displayed;\n",
        "CC       Name=2B; Synonyms=K-Ras4B;\n",
        "CC         IsoId=P01116-2, P01118-1;\n",
        "CC         Sequence=VSP_011140, VSP_011141;\n",
        "CC         Note=Variant in position: 152:V->G (in NS3). Variant in\n",
        "CC         position: 153:D->V (in CFC2 and NS3, exhibits only minor\n",
        "CC         alterations in its in vitro biochemical behavior compared to\n",
        "CC         wild-type protein). Variant in position: 156:F->I (in NS3/CFC2).\n",
        "CC         Variant in position: 156:F->L (found in a patient with Costello\n",
        "CC         syndrome, exhibits an increase in intrinsic and guanine\n",
        "CC         nucleotide exchange factor catalyzed nucleotide exchange in\n",
        "CC         combination with an impaired GTPase-activating\n",
        "CC         protein-stimulated GTP hydrolysis but functional in interaction\n",
        "CC         with effectors);\n",
        "CC   -!- PTM: Acetylation at Lys-104 prevents interaction with guanine\n",
        "CC       nucleotide exchange factors (GEFs).\n",
        "CC   -!- DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype\n",
        "CC       of acute leukemia, a cancer of the white blood cells. AML is a\n",
        "CC       malignant disease of bone marrow characterized by maturational\n",
        "CC       arrest of hematopoietic precursors at an early stage of\n",
        "CC       development. Clonal expansion of myeloid blasts occurs in bone\n",
        "CC       marrow, blood, and other tissue. Myelogenous leukemias develop\n",
        "CC       from changes in cells that normally produce neutrophils,\n",
        "CC       basophils, eosinophils and monocytes. Note=The disease is caused\n",
        "CC       by mutations affecting the gene represented in this entry.\n",
        "CC   -!- DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An\n",
        "CC       aggressive pediatric myelodysplastic syndrome/myeloproliferative\n",
        "CC       disorder characterized by malignant transformation in the\n",
        "CC       hematopoietic stem cell compartment with proliferation of\n",
        "CC       differentiated progeny. Patients have splenomegaly, enlarged lymph\n",
        "CC       nodes, rashes, and hemorrhages. Note=The disease is caused by\n",
        "CC       mutations affecting the gene represented in this entry.\n",
        "CC   -!- DISEASE: Noonan syndrome 3 (NS3) [MIM:609942]: A form of Noonan\n",
        "CC       syndrome, a disease characterized by short stature, facial\n",
        "CC       dysmorphic features such as hypertelorism, a downward eyeslant and\n",
        "CC       low-set posteriorly rotated ears, and a high incidence of\n",
        "CC       congenital heart defects and hypertrophic cardiomyopathy. Other\n",
        "CC       features can include a short neck with webbing or redundancy of\n",
        "CC       skin, deafness, motor delay, variable intellectual deficits,\n",
        "CC       multiple skeletal defects, cryptorchidism, and bleeding diathesis.\n",
        "CC       Individuals with Noonan syndrome are at risk of juvenile\n",
        "CC       myelomonocytic leukemia, a myeloproliferative disorder\n",
        "CC       characterized by excessive production of myelomonocytic cells.\n",
        "CC       Note=The disease is caused by mutations affecting the gene\n",
        "CC       represented in this entry.\n",
        "CC   -!- DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease\n",
        "CC       which starts in the stomach, can spread to the esophagus or the\n",
        "CC       small intestine, and can extend through the stomach wall to nearby\n",
        "CC       lymph nodes and organs. It also can metastasize to other parts of\n",
        "CC       the body. The term gastric cancer or gastric carcinoma refers to\n",
        "CC       adenocarcinoma of the stomach that accounts for most of all\n",
        "CC       gastric malignant tumors. Two main histologic types are\n",
        "CC       recognized, diffuse type and intestinal type carcinomas. Diffuse\n",
        "CC       tumors are poorly differentiated infiltrating lesions, resulting\n",
        "CC       in thickening of the stomach. In contrast, intestinal tumors are\n",
        "CC       usually exophytic, often ulcerating, and associated with\n",
        "CC       intestinal metaplasia of the stomach, most often observed in\n",
        "CC       sporadic disease. Note=The disease is caused by mutations\n",
        "CC       affecting the gene represented in this entry.\n",
        "CC   -!- DISEASE: Note=Defects in KRAS are a cause of pylocytic astrocytoma\n",
        "CC       (PA). Pylocytic astrocytomas are neoplasms of the brain and spinal\n",
        "CC       cord derived from glial cells which vary from histologically\n",
        "CC       benign forms to highly anaplastic and malignant tumors.\n",
        "CC   -!- DISEASE: Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]: A\n",
        "CC       form of cardiofaciocutaneous syndrome, a multiple congenital\n",
        "CC       anomaly disorder characterized by a distinctive facial appearance,\n",
        "CC       heart defects and mental retardation. Heart defects include\n",
        "CC       pulmonic stenosis, atrial septal defects and hypertrophic\n",
        "CC       cardiomyopathy. Some affected individuals present with ectodermal\n",
        "CC       abnormalities such as sparse, friable hair, hyperkeratotic skin\n",
        "CC       lesions and a generalized ichthyosis-like condition. Typical\n",
        "CC       facial features are similar to Noonan syndrome. They include high\n",
        "CC       forehead with bitemporal constriction, hypoplastic supraorbital\n",
        "CC       ridges, downslanting palpebral fissures, a depressed nasal bridge,\n",
        "CC       and posteriorly angulated ears with prominent helices. CFC2\n",
        "CC       patients often do not have the skin abnormalities, such as\n",
        "CC       ichthyosis, hyperkeratosis, and hemangioma observed in CFC1.\n",
        "CC       Note=The disease is caused by mutations affecting the gene\n",
        "CC       represented in this entry.\n",
        "CC   -!- DISEASE: Note=KRAS mutations are involved in cancer development.\n",
        "CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Ras family.\n",
        "CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology\n",
        "CC       and Haematology;\n",
        "CC       URL=\"http://atlasgeneticsoncology.org/Genes/KRASID91.html\";\n",
        "CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and\n",
        "CC       polymorphism database;\n",
        "CC       URL=\"http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=KRAS\";\n",
        "CC   -----------------------------------------------------------------------\n",
        "CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms\n",
        "CC   Distributed under the Creative Commons Attribution-NoDerivs License\n",
        "CC   -----------------------------------------------------------------------\n",
        "DR   EMBL; L00049; AAB59444.1; -; Genomic_DNA.\n",
        "DR   EMBL; L00045; AAB59444.1; JOINED; Genomic_DNA.\n",
        "DR   EMBL; L00046; AAB59444.1; JOINED; Genomic_DNA.\n",
        "DR   EMBL; L00047; AAB59444.1; JOINED; Genomic_DNA.\n",
        "DR   EMBL; L00048; AAB59445.1; -; Genomic_DNA.\n",
        "DR   EMBL; L00045; AAB59445.1; JOINED; Genomic_DNA.\n",
        "DR   EMBL; L00046; AAB59445.1; JOINED; Genomic_DNA.\n",
        "DR   EMBL; L00047; AAB59445.1; JOINED; Genomic_DNA.\n",
        "DR   EMBL; M54968; AAB41942.1; -; mRNA.\n",
        "DR   EMBL; AF493917; AAM12631.1; -; mRNA.\n",
        "DR   EMBL; BT007153; AAP35817.1; -; mRNA.\n",
        "DR   EMBL; AK292510; BAF85199.1; -; mRNA.\n",
        "DR   EMBL; CH471094; EAW96511.1; -; Genomic_DNA.\n",
        "DR   EMBL; CH471094; EAW96512.1; -; Genomic_DNA.\n",
        "DR   EMBL; EU332849; ABY87538.1; -; Genomic_DNA.\n",
        "DR   EMBL; BC013572; AAH13572.1; -; mRNA.\n",
        "DR   EMBL; K01519; -; NOT_ANNOTATED_CDS; Genomic_DNA.\n",
        "DR   EMBL; K01520; -; NOT_ANNOTATED_CDS; Genomic_DNA.\n",
        "DR   EMBL; M25876; AAA35683.1; -; Genomic_DNA.\n",
        "DR   EMBL; M34904; AAA36149.1; -; Genomic_DNA.\n",
        "DR   EMBL; M30539; AAA36557.1; -; Genomic_DNA.\n",
        "DR   EMBL; X01669; CAA25828.1; -; Genomic_DNA.\n",
        "DR   EMBL; X02825; CAA26593.1; -; Genomic_DNA.\n",
        "DR   EMBL; K03210; AAA36554.1; -; Genomic_DNA.\n",
        "DR   EMBL; K03209; AAA36554.1; JOINED; Genomic_DNA.\n",
        "DR   CCDS; CCDS8702.1; -. [P01116-2]\n",
        "DR   CCDS; CCDS8703.1; -. [P01116-1]\n",
        "DR   PIR; A93311; TVHUK.\n",
        "DR   PIR; B93311; TVHU2K.\n",
        "DR   RefSeq; NP_004976.2; NM_004985.4. [P01116-2]\n",
        "DR   RefSeq; NP_203524.1; NM_033360.3. [P01116-1]\n",
        "DR   RefSeq; XP_006719132.1; XM_006719069.1. [P01116-1]\n",
        "DR   UniGene; Hs.37003; -.\n",
        "DR   UniGene; Hs.505033; -.\n",
        "DR   PDB; 1D8D; X-ray; 2.00 A; P=178-188.\n",
        "DR   PDB; 1D8E; X-ray; 3.00 A; P=178-188.\n",
        "DR   PDB; 1KZO; X-ray; 2.20 A; C=169-173.\n",
        "DR   PDB; 1KZP; X-ray; 2.10 A; C=169-173.\n",
        "DR   PDB; 3GFT; X-ray; 2.27 A; A/B/C/D/E/F=1-164.\n",
        "DR   PDB; 4DSN; X-ray; 2.03 A; A=2-164.\n",
        "DR   PDB; 4DSO; X-ray; 1.85 A; A=2-164.\n",
        "DR   PDB; 4EPR; X-ray; 2.00 A; A=1-164.\n",
        "DR   PDB; 4EPT; X-ray; 2.00 A; A=1-164.\n",
        "DR   PDB; 4EPV; X-ray; 1.35 A; A=1-164.\n",
        "DR   PDB; 4EPW; X-ray; 1.70 A; A=1-164.\n",
        "DR   PDB; 4EPX; X-ray; 1.76 A; A=1-164.\n",
        "DR   PDB; 4EPY; X-ray; 1.80 A; A=1-164.\n",
        "DR   PDB; 4L8G; X-ray; 1.52 A; A=1-169.\n",
        "DR   PDB; 4LPK; X-ray; 1.50 A; A/B=1-169.\n",
        "DR   PDB; 4LRW; X-ray; 2.15 A; A/B=1-169.\n",
        "DR   PDB; 4LUC; X-ray; 1.29 A; A/B=1-169.\n",
        "DR   PDB; 4LV6; X-ray; 1.50 A; A/B=1-169.\n",
        "DR   PDB; 4LYF; X-ray; 1.57 A; A/B/C=1-169.\n",
        "DR   PDB; 4LYH; X-ray; 1.37 A; A/B/C=1-169.\n",
        "DR   PDB; 4LYJ; X-ray; 1.93 A; A=1-169.\n",
        "DR   PDB; 4M1O; X-ray; 1.57 A; A/B/C=1-169.\n",
        "DR   PDB; 4M1S; X-ray; 1.55 A; A/B/C=1-169.\n",
        "DR   PDB; 4M1T; X-ray; 1.70 A; A/B/C=1-169.\n",
        "DR   PDB; 4M1W; X-ray; 1.58 A; A/B/C=1-169.\n",
        "DR   PDB; 4M1Y; X-ray; 1.49 A; A/B/C=1-169.\n",
        "DR   PDB; 4M21; X-ray; 1.94 A; A/B/C=1-169.\n",
        "DR   PDB; 4M22; X-ray; 2.09 A; A/B/C=1-169.\n",
        "DR   PDBsum; 1D8D; -.\n",
        "DR   PDBsum; 1D8E; -.\n",
        "DR   PDBsum; 1KZO; -.\n",
        "DR   PDBsum; 1KZP; -.\n",
        "DR   PDBsum; 3GFT; -.\n",
        "DR   PDBsum; 4DSN; -.\n",
        "DR   PDBsum; 4DSO; -.\n",
        "DR   PDBsum; 4EPR; -.\n",
        "DR   PDBsum; 4EPT; -.\n",
        "DR   PDBsum; 4EPV; -.\n",
        "DR   PDBsum; 4EPW; -.\n",
        "DR   PDBsum; 4EPX; -.\n",
        "DR   PDBsum; 4EPY; -.\n",
        "DR   PDBsum; 4L8G; -.\n",
        "DR   PDBsum; 4LPK; -.\n",
        "DR   PDBsum; 4LRW; -.\n",
        "DR   PDBsum; 4LUC; -.\n",
        "DR   PDBsum; 4LV6; -.\n",
        "DR   PDBsum; 4LYF; -.\n",
        "DR   PDBsum; 4LYH; -.\n",
        "DR   PDBsum; 4LYJ; -.\n",
        "DR   PDBsum; 4M1O; -.\n",
        "DR   PDBsum; 4M1S; -.\n",
        "DR   PDBsum; 4M1T; -.\n",
        "DR   PDBsum; 4M1W; -.\n",
        "DR   PDBsum; 4M1Y; -.\n",
        "DR   PDBsum; 4M21; -.\n",
        "DR   PDBsum; 4M22; -.\n",
        "DR   ProteinModelPortal; P01116; -.\n",
        "DR   SMR; P01116; 1-166.\n",
        "DR   BioGrid; 110043; 32.\n",
        "DR   DIP; DIP-33951N; -.\n",
        "DR   IntAct; P01116; 21.\n",
        "DR   MINT; MINT-131580; -.\n",
        "DR   STRING; 9606.ENSP00000256078; -.\n",
        "DR   ChEMBL; CHEMBL2189121; -.\n",
        "DR   PhosphoSite; P01116; -.\n",
        "DR   DMDM; 131875; -.\n",
        "DR   MaxQB; P01116; -.\n",
        "DR   PaxDb; P01116; -.\n",
        "DR   PeptideAtlas; P01116; -.\n",
        "DR   PRIDE; P01116; -.\n",
        "DR   DNASU; 3845; -.\n",
        "DR   Ensembl; ENST00000256078; ENSP00000256078; ENSG00000133703. [P01116-1]\n",
        "DR   Ensembl; ENST00000311936; ENSP00000308495; ENSG00000133703. [P01116-2]\n",
        "DR   GeneID; 3845; -.\n",
        "DR   KEGG; hsa:3845; -.\n",
        "DR   UCSC; uc001rgp.1; human. [P01116-1]\n",
        "DR   UCSC; uc001rgq.1; human. [P01116-2]\n",
        "DR   CTD; 3845; -.\n",
        "DR   GeneCards; GC12M025358; -.\n",
        "DR   GeneReviews; KRAS; -.\n",
        "DR   HGNC; HGNC:6407; KRAS.\n",
        "DR   MIM; 190070; gene.\n",
        "DR   MIM; 601626; phenotype.\n",
        "DR   MIM; 607785; phenotype.\n",
        "DR   MIM; 609942; phenotype.\n",
        "DR   MIM; 613659; phenotype.\n",
        "DR   MIM; 615278; phenotype.\n",
        "DR   neXtProt; NX_P01116; -.\n",
        "DR   Orphanet; 1340; Cardiofaciocutaneous syndrome.\n",
        "DR   Orphanet; 3071; Costello syndrome.\n",
        "DR   Orphanet; 1333; Familial pancreatic carcinoma.\n",
        "DR   Orphanet; 144; Hereditary nonpolyposis colon cancer.\n",
        "DR   Orphanet; 86834; Juvenile myelomonocytic leukemia.\n",
        "DR   Orphanet; 2612; Linear nevus sebaceus syndrome.\n",
        "DR   Orphanet; 648; Noonan syndrome.\n",
        "DR   Orphanet; 251612; Pilocytic astrocytoma.\n",
        "DR   Orphanet; 357194; Selection of therapeutic option in colorectal cancer.\n",
        "DR   Orphanet; 357191; Selection of therapeutic option in non-small cell lung carcinoma.\n",
        "DR   PharmGKB; PA30196; -.\n",
        "DR   eggNOG; COG1100; -.\n",
        "DR   HOGENOM; HOG000233973; -.\n",
        "DR   HOVERGEN; HBG009351; -.\n",
        "DR   InParanoid; P01116; -.\n",
        "DR   KO; K07827; -.\n",
        "DR   OMA; RRYNREM; -.\n",
        "DR   OrthoDB; EOG7QVM41; -.\n",
        "DR   PhylomeDB; P01116; -.\n",
        "DR   TreeFam; TF312796; -.\n",
        "DR   Reactome; REACT_111045; Developmental Biology.\n",
        "DR   Reactome; REACT_111102; Signal Transduction.\n",
        "DR   Reactome; REACT_116125; Disease.\n",
        "DR   Reactome; REACT_604; Hemostasis.\n",
        "DR   Reactome; REACT_6900; Immune System.\n",
        "DR   SignaLink; P01116; -.\n",
        "DR   ChiTaRS; KRAS; human.\n",
        "DR   EvolutionaryTrace; P01116; -.\n",
        "DR   GeneWiki; KRAS; -.\n",
        "DR   GenomeRNAi; 3845; -.\n",
        "DR   NextBio; 15131; -.\n",
        "DR   PRO; PR:P01116; -.\n",
        "DR   ArrayExpress; P01116; -.\n",
        "DR   Bgee; P01116; -.\n",
        "DR   CleanEx; HS_KRAS; -.\n",
        "DR   Genevestigator; P01116; -.\n",
        "DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.\n",
        "DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.\n",
        "DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.\n",
        "DR   GO; GO:0019003; F:GDP binding; IEA:Ensembl.\n",
        "DR   GO; GO:0019002; F:GMP binding; IEA:Ensembl.\n",
        "DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.\n",
        "DR   GO; GO:0005515; F:protein binding; IPI:IntAct.\n",
        "DR   GO; GO:0032403; F:protein complex binding; IDA:MGI.\n",
        "DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl.\n",
        "DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:Reactome.\n",
        "DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.\n",
        "DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.\n",
        "DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl.\n",
        "DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome.\n",
        "DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.\n",
        "DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.\n",
        "DR   GO; GO:0006184; P:GTP catabolic process; IEA:InterPro.\n",
        "DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.\n",
        "DR   GO; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome.\n",
        "DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.\n",
        "DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.\n",
        "DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.\n",
        "DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome.\n",
        "DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.\n",
        "DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.\n",
        "DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl.\n",
        "DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl.\n",
        "DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IEA:Ensembl.\n",
        "DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL.\n",
        "DR   GO; GO:0035022; P:positive regulation of Rac protein signal transduction; IEA:Ensembl.\n",
        "DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:Reactome.\n",
        "DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl.\n",
        "DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl.\n",
        "DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.\n",
        "DR   GO; GO:0051385; P:response to mineralocorticoid; IEA:Ensembl.\n",
        "DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome.\n",
        "DR   GO; GO:0035176; P:social behavior; IEA:Ensembl.\n",
        "DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.\n",
        "DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.\n",
        "DR   Gene3D; 3.40.50.300; -; 1.\n",
        "DR   InterPro; IPR027417; P-loop_NTPase.\n",
        "DR   InterPro; IPR005225; Small_GTP-bd_dom.\n",
        "DR   InterPro; IPR001806; Small_GTPase.\n",
        "DR   InterPro; IPR020849; Small_GTPase_Ras.\n",
        "DR   PANTHER; PTHR24070; PTHR24070; 1.\n",
        "DR   Pfam; PF00071; Ras; 1.\n",
        "DR   PRINTS; PR00449; RASTRNSFRMNG.\n",
        "DR   SMART; SM00173; RAS; 1.\n",
        "DR   SUPFAM; SSF52540; SSF52540; 1.\n",
        "DR   TIGRFAMs; TIGR00231; small_GTP; 1.\n",
        "DR   PROSITE; PS51421; RAS; 1.\n",
        "PE   1: Evidence at protein level;\n",
        "KW   3D-structure; Acetylation; Alternative splicing; Cardiomyopathy;\n",
        "KW   Cell membrane; Complete proteome; Deafness; Direct protein sequencing;\n",
        "KW   Disease mutation; Ectodermal dysplasia; GTP-binding; Lipoprotein;\n",
        "KW   Membrane; Mental retardation; Methylation; Nucleotide-binding;\n",
        "KW   Palmitate; Polymorphism; Prenylation; Proto-oncogene;\n",
        "KW   Reference proteome.\n",
        "FT   CHAIN         1    186       GTPase KRas.\n",
        "FT                                /FTId=PRO_0000082641.\n",
        "FT   INIT_MET      1      1       Removed; alternate.\n",
        "FT   CHAIN         2    186       GTPase KRas, N-terminally processed.\n",
        "FT                                /FTId=PRO_0000326480.\n",
        "FT   PROPEP      187    189       Removed in mature form.\n",
        "FT                                /FTId=PRO_0000281291.\n",
        "FT   NP_BIND      10     17       GTP.\n",
        "FT   NP_BIND      57     61       GTP.\n",
        "FT   NP_BIND     116    119       GTP.\n",
        "FT   REGION      166    185       Hypervariable region.\n",
        "FT   MOTIF        32     40       Effector region.\n",
        "FT   MOD_RES       1      1       N-acetylmethionine; in GTPase KRas;\n",
        "FT                                alternate.\n",
        "FT   MOD_RES       2      2       N-acetylthreonine; in GTPase KRas, N-\n",
        "FT                                terminally processed.\n",
        "FT   MOD_RES     104    104       N6-acetyllysine.\n",
        "FT   MOD_RES     186    186       Cysteine methyl ester (By similarity).\n",
        "FT   LIPID       180    180       S-palmitoyl cysteine (By similarity).\n",
        "FT   LIPID       186    186       S-farnesyl cysteine (By similarity).\n",
        "FT   VAR_SEQ     151    153       RVE -> GVD (in isoform 2B).\n",
        "FT                                /FTId=VSP_011140.\n",
        "FT   VAR_SEQ     165    189       QYRLKKISKEEKTPGCVKIKKCIIM -> KHKEKMSKDGKK\n",
        "FT                                KKKKSKTKCVIM (in isoform 2B).\n",
        "FT                                /FTId=VSP_011141.\n",
        "FT   VARIANT       5      5       K -> E (in NS3).\n",
        "FT                                /FTId=VAR_065144.\n",
        "FT   VARIANT       5      5       K -> N (in GASC; found also in a patient\n",
        "FT                                with Costello syndrome; exhibits only\n",
        "FT                                minor alterations in its in vitro\n",
        "FT                                biochemical behavior compared to wild-\n",
        "FT                                type protein).\n",
        "FT                                /FTId=VAR_064849.\n",
        "FT   VARIANT      10     10       G -> GG (in one individual with AML;\n",
        "FT                                expression in 3T3 cell causes cellular\n",
        "FT                                transformation; expression in COS cells\n",
        "FT                                activates the Ras-MAPK signaling pathway;\n",
        "FT                                lower GTPase activity; faster GDP\n",
        "FT                                dissociation rate).\n",
        "FT                                /FTId=VAR_034601.\n",
        "FT   VARIANT      12     12       G -> A (in a colorectal cancer sample;\n",
        "FT                                somatic mutation).\n",
        "FT                                /FTId=VAR_036305.\n",
        "FT   VARIANT      12     12       G -> C (in lung carcinoma; somatic\n",
        "FT                                mutation).\n",
        "FT                                /FTId=VAR_006839.\n",
        "FT   VARIANT      12     12       G -> D (in pancreatic carcinoma, GASC and\n",
        "FT                                lung carcinoma; somatic mutation).\n",
        "FT                                /FTId=VAR_016026.\n",
        "FT   VARIANT      12     12       G -> R (in lung cancer and bladder\n",
        "FT                                cancer; somatic mutation).\n",
        "FT                                /FTId=VAR_016027.\n",
        "FT   VARIANT      12     12       G -> S (in lung carcinoma and GASC;\n",
        "FT                                somatic mutation).\n",
        "FT                                /FTId=VAR_016028.\n",
        "FT   VARIANT      12     12       G -> V (in lung carcinoma, pancreatic\n",
        "FT                                carcinoma, colon cancer and GASC; somatic\n",
        "FT                                mutation, constitutively activated).\n",
        "FT                                /FTId=VAR_006840.\n",
        "FT   VARIANT      13     13       G -> D (in a breast carcinoma cell line\n",
        "FT                                and GASC; somatic mutation).\n",
        "FT                                /FTId=VAR_016029.\n",
        "FT   VARIANT      13     13       G -> R (in pylocytic astrocytoma; somatic\n",
        "FT                                mutation; increase activation of the Ras\n",
        "FT                                pathway).\n",
        "FT                                /FTId=VAR_065145.\n",
        "FT   VARIANT      14     14       V -> I (in NS3; affects activity and\n",
        "FT                                impairs responsiveness to GTPase\n",
        "FT                                activating proteins; characterized by a\n",
        "FT                                strong increase of both intrinsic and\n",
        "FT                                guanine nucleotide exchanged factor-\n",
        "FT                                catalyzed nucleotide exchange leading to\n",
        "FT                                an increased level of the activated\n",
        "FT                                state).\n",
        "FT                                /FTId=VAR_026109.\n",
        "FT   VARIANT      22     22       Q -> E (in CFC2; exhibits an increase in\n",
        "FT                                intrinsic and guanine nucleotide exchange\n",
        "FT                                factor catalyzed nucleotide exchange in\n",
        "FT                                combination with an impaired GTPase-\n",
        "FT                                activating protein-stimulated GTP\n",
        "FT                                hydrolysis but functional in interaction\n",
        "FT                                with effectors).\n",
        "FT                                /FTId=VAR_064850.\n",
        "FT   VARIANT      22     22       Q -> R (in NS3; impairs GTPase-activating\n",
        "FT                                protein stimulated GTP hydrolysis with\n",
        "FT                                unaffected intrinsic functions and a\n",
        "FT                                virtually functional effector\n",
        "FT                                interaction).\n",
        "FT                                /FTId=VAR_064851.\n",
        "FT   VARIANT      34     34       P -> L (in NS3; characterized by a\n",
        "FT                                defective GTPase-activating protein\n",
        "FT                                sensitivity and a strongly reduced\n",
        "FT                                interaction with effectors).\n",
        "FT                                /FTId=VAR_064852.\n",
        "FT   VARIANT      34     34       P -> Q (in NS3).\n",
        "FT                                /FTId=VAR_064853.\n",
        "FT   VARIANT      34     34       P -> R (in CFC2; characterized by a\n",
        "FT                                defective GTPase-activating protein\n",
        "FT                                sensitivity and a strongly reduced\n",
        "FT                                interaction with effectors).\n",
        "FT                                /FTId=VAR_026110.\n",
        "FT   VARIANT      36     36       I -> M (in NS3).\n",
        "FT                                /FTId=VAR_064854.\n",
        "FT   VARIANT      58     58       T -> I (in NS3; affects activity and\n",
        "FT                                impairs responsiveness to GTPase\n",
        "FT                                activating proteins; exhibits only minor\n",
        "FT                                alterations in its in vitro biochemical\n",
        "FT                                behavior compared to wild-type protein).\n",
        "FT                                /FTId=VAR_026111.\n",
        "FT   VARIANT      59     59       A -> T (in bladder cancer and GASC;\n",
        "FT                                somatic mutation).\n",
        "FT                                /FTId=VAR_016030.\n",
        "FT   VARIANT      60     60       G -> R (in CFC2; characterized by a\n",
        "FT                                defective GTPase-activating protein\n",
        "FT                                sensitivity and a strongly reduced\n",
        "FT                                interaction with effectors).\n",
        "FT                                /FTId=VAR_026112.\n",
        "FT   VARIANT      60     60       G -> S (in NS3).\n",
        "FT                                /FTId=VAR_065146.\n",
        "FT   VARIANT      61     61       Q -> H (in lung carcinoma;\n",
        "FT                                dbSNP:rs17851045).\n",
        "FT                                /FTId=VAR_006841.\n",
        "FT   VARIANT      61     61       Q -> R (in a colorectal cancer sample;\n",
        "FT                                somatic mutation).\n",
        "FT                                /FTId=VAR_036306.\n",
        "FT   VARIANT      71     71       Y -> H (in CFC2).\n",
        "FT                                /FTId=VAR_069784.\n",
        "FT   VARIANT     117    117       K -> N (in a colorectal cancer sample;\n",
        "FT                                somatic mutation).\n",
        "FT                                /FTId=VAR_036307.\n",
        "FT   VARIANT     146    146       A -> T (in a colorectal cancer sample;\n",
        "FT                                somatic mutation).\n",
        "FT                                /FTId=VAR_036308.\n",
        "FT   VARIANT     147    147       K -> E (in CFC2).\n",
        "FT                                /FTId=VAR_069785.\n",
        "FT   MUTAGEN     164    164       R->A: Loss of GTP-binding activity.\n",
        "FT   STRAND        2     11\n",
        "FT   HELIX        16     25\n",
        "FT   STRAND       38     46\n",
        "FT   STRAND       49     57\n",
        "FT   HELIX        61     63\n",
        "FT   HELIX        66     74\n",
        "FT   STRAND       76     83\n",
        "FT   HELIX        87    103\n",
        "FT   TURN        104    106\n",
        "FT   STRAND      111    116\n",
        "FT   STRAND      120    122\n",
        "FT   HELIX       127    137\n",
        "FT   STRAND      141    143\n",
        "FT   TURN        146    148\n",
        "FT   HELIX       152    167\n",
        "SQ   SEQUENCE   189 AA;  21656 MW;  973547B2E11C2C81 CRC64;\n",
        "     MTEYKLVVVG AGGVGKSALT IQLIQNHFVD EYDPTIEDSY RKQVVIDGET CLLDILDTAG\n",
        "     QEEYSAMRDQ YMRTGEGFLC VFAINNTKSF EDIHHYREQI KRVKDSEDVP MVLVGNKCDL\n",
        "     PSRTVDTKQA QDLARSYGIP FIETSAKTRQ RVEDAFYTLV REIRQYRLKK ISKEEKTPGC\n",
        "     VKIKKCIIM\n",
        "//\n",
        "\n"
       ]
      }
     ],
     "prompt_number": 3
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "line = uni_txt.splitlines()\n",
      "type(line)\n",
      "\n",
      "def item_generator(src):\n",
      "    \"\"\"Return a generator that produces a FASTA sequence from src\n",
      "    each time it is called\"\"\"\n",
      "    tag = None\n",
      "    uniprot_id = None\n",
      "    metadata_by_acc = {}\n",
      "    \n",
      "    for t in uni_txt.splitlines():\n",
      "        tag, value = \n",
      "        for l in line:\n",
      "            key, value = l[:5].strip, l[5:].strip\n",
      "        assert is_feature_start(line)      # line should start a feature\n",
      "        feature, line = read_feature(src, line)\n",
      "        # need to keep line to feed back to read_feature\n",
      "        yield feature"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 12,
       "text": [
        "list"
       ]
      }
     ],
     "prompt_number": 12
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "uni_txt.splitlines()"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 11,
       "text": [
        "[u'ID   BRAF_HUMAN              Reviewed;         766 AA.',\n",
        " u'AC   P15056; A4D1T4; B6HY61; B6HY62; B6HY63; B6HY64; B6HY65; B6HY66;',\n",
        " u'AC   Q13878; Q3MIN6; Q9UDP8; Q9Y6T3;',\n",
        " u'DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.',\n",
        " u'DT   19-JUL-2004, sequence version 4.',\n",
        " u'DT   09-JUL-2014, entry version 183.',\n",
        " u'DE   RecName: Full=Serine/threonine-protein kinase B-raf;',\n",
        " u'DE            EC=2.7.11.1;',\n",
        " u'DE   AltName: Full=Proto-oncogene B-Raf;',\n",
        " u'DE   AltName: Full=p94;',\n",
        " u'DE   AltName: Full=v-Raf murine sarcoma viral oncogene homolog B1;',\n",
        " u'GN   Name=BRAF; Synonyms=BRAF1, RAFB1;',\n",
        " u'OS   Homo sapiens (Human).',\n",
        " u'OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;',\n",
        " u'OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;',\n",
        " u'OC   Catarrhini; Hominidae; Homo.',\n",
        " u'OX   NCBI_TaxID=9606;',\n",
        " u'RN   [1]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND',\n",
        " u'RP   PHOSPHORYLATION AT THR-373.',\n",
        " u'RC   TISSUE=Testis;',\n",
        " u'RX   PubMed=1508179;',\n",
        " u'RA   Stephens R.M., Sithanandam G., Copeland T.D., Kaplan D.R., Rapp U.R.,',\n",
        " u'RA   Morrison D.K.;',\n",
        " u'RT   \"95-kilodalton B-Raf serine/threonine kinase: identification of the',\n",
        " u'RT   protein and its major autophosphorylation site.\";',\n",
        " u'RL   Mol. Cell. Biol. 12:3733-3742(1992).',\n",
        " u'RN   [2]',\n",
        " u'RP   SEQUENCE REVISION TO 31-33.',\n",
        " u'RA   Albert S., Wixler L., Rapp U.R.;',\n",
        " u'RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.',\n",
        " u'RN   [3]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].',\n",
        " u'RG   NIEHS SNPs program;',\n",
        " u'RL   Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.',\n",
        " u'RN   [4]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].',\n",
        " u'RX   PubMed=12690205; DOI=10.1126/science.1083423;',\n",
        " u'RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,',\n",
        " u'RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,',\n",
        " u'RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,',\n",
        " u'RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,',\n",
        " u'RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,',\n",
        " u'RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,',\n",
        " u'RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,',\n",
        " u'RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,',\n",
        " u'RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,',\n",
        " u'RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,',\n",
        " u'RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,',\n",
        " u'RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,',\n",
        " u'RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,',\n",
        " u'RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,',\n",
        " u'RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,',\n",
        " u'RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,',\n",
        " u'RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,',\n",
        " u'RA   Mural R.J., Adams M.D., Tsui L.-C.;',\n",
        " u'RT   \"Human chromosome 7: DNA sequence and biology.\";',\n",
        " u'RL   Science 300:767-772(2003).',\n",
        " u'RN   [5]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].',\n",
        " u'RX   PubMed=12853948; DOI=10.1038/nature01782;',\n",
        " u'RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,',\n",
        " u'RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,',\n",
        " u\"RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,\",\n",
        " u'RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,',\n",
        " u'RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,',\n",
        " u'RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,',\n",
        " u'RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,',\n",
        " u'RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,',\n",
        " u'RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,',\n",
        " u'RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,',\n",
        " u'RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,',\n",
        " u'RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,',\n",
        " u'RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,',\n",
        " u'RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,',\n",
        " u'RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,',\n",
        " u'RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,',\n",
        " u'RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,',\n",
        " u'RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,',\n",
        " u'RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,',\n",
        " u'RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,',\n",
        " u'RA   Waterston R.H., Wilson R.K.;',\n",
        " u'RT   \"The DNA sequence of human chromosome 7.\";',\n",
        " u'RL   Nature 424:157-164(2003).',\n",
        " u'RN   [6]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].',\n",
        " u'RC   TISSUE=Liver;',\n",
        " u'RX   PubMed=15489334; DOI=10.1101/gr.2596504;',\n",
        " u'RG   The MGC Project Team;',\n",
        " u'RT   \"The status, quality, and expansion of the NIH full-length cDNA',\n",
        " u'RT   project: the Mammalian Gene Collection (MGC).\";',\n",
        " u'RL   Genome Res. 14:2121-2127(2004).',\n",
        " u'RN   [7]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-200.',\n",
        " u'RC   TISSUE=Placenta;',\n",
        " u'RX   PubMed=1630826;',\n",
        " u'RA   Eychene A., Barnier J.V., Apiou F., Dutrillaux B., Calothy G.;',\n",
        " u'RT   \"Chromosomal assignment of two human B-raf(Rmil) proto-oncogene loci:',\n",
        " u'RT   B-raf-1 encoding the p94Braf/Rmil and B-raf-2, a processed',\n",
        " u'RT   pseudogene.\";',\n",
        " u'RL   Oncogene 7:1657-1660(1992).',\n",
        " u'RN   [8]',\n",
        " u'RP   PROTEIN SEQUENCE OF 2-51; 56-95; 151-158; 189-199; 253-260; 294-354;',\n",
        " u'RP   361-424; 444-507; 510-522; 559-570; 579-626; 663-680; 692-698;',\n",
        " u'RP   702-719; 727-735 AND 753-766, CLEAVAGE OF INITIATOR METHIONINE,',\n",
        " u'RP   ACETYLATION AT ALA-2, PHOSPHORYLATION AT SER-365; THR-396; SER-399;',\n",
        " u'RP   THR-401 AND SER-729, AND IDENTIFICATION BY MASS SPECTROMETRY.',\n",
        " u'RC   TISSUE=Colon carcinoma, and Hepatoma;',\n",
        " u'RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Zebisch A., Kolch W.;',\n",
        " u'RL   Submitted (DEC-2008) to UniProtKB.',\n",
        " u'RN   [9]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-766.',\n",
        " u'RC   TISSUE=Testis;',\n",
        " u'RX   PubMed=2284096;',\n",
        " u'RA   Sithanandam G., Kolch W., Duh F.-M., Rapp U.R.;',\n",
        " u'RT   \"Complete coding sequence of a human B-raf cDNA and detection of B-raf',\n",
        " u'RT   protein kinase with isozyme specific antibodies.\";',\n",
        " u'RL   Oncogene 5:1775-1780(1990).',\n",
        " u'RN   [10]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [MRNA] OF 381-766, DISEASE, AND CHROMOSOMAL',\n",
        " u'RP   REARRANGEMENT.',\n",
        " u'RC   TISSUE=Brain;',\n",
        " u'RX   PubMed=18974108; DOI=10.1158/0008-5472.CAN-08-2097;',\n",
        " u'RA   Jones D.T.W., Kocialkowski S., Liu L., Pearson D.M., Backlund L.M.,',\n",
        " u'RA   Ichimura K., Collins V.P.;',\n",
        " u'RT   \"Tandem duplication producing a novel oncogenic BRAF fusion gene',\n",
        " u'RT   defines the majority of pilocytic astrocytomas.\";',\n",
        " u'RL   Cancer Res. 68:8673-8677(2008).',\n",
        " u'RN   [11]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [MRNA] OF 439-766.',\n",
        " u'RX   PubMed=3043188;',\n",
        " u'RA   Ikawa S., Fukui M., Ueyama Y., Tamaoki N., Yamamoto T., Toyoshima K.;',\n",
        " u'RT   \"B-raf, a new member of the raf family, is activated by DNA',\n",
        " u'RT   rearrangement.\";',\n",
        " u'RL   Mol. Cell. Biol. 8:2651-2654(1988).',\n",
        " u'RN   [12]',\n",
        " u'RP   PHOSPHORYLATION AT SER-365 BY SGK1.',\n",
        " u'RX   PubMed=11410590; DOI=10.1074/jbc.M102808200;',\n",
        " u'RA   Zhang B.H., Tang E.D., Zhu T., Greenberg M.E., Vojtek A.B., Guan K.L.;',\n",
        " u'RT   \"Serum- and glucocorticoid-inducible kinase SGK phosphorylates and',\n",
        " u'RT   negatively regulates B-Raf.\";',\n",
        " u'RL   J. Biol. Chem. 276:31620-31626(2001).',\n",
        " u'RN   [13]',\n",
        " u'RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401, AND IDENTIFICATION',\n",
        " u'RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].',\n",
        " u'RC   TISSUE=Cervix carcinoma;',\n",
        " u'RX   PubMed=16964243; DOI=10.1038/nbt1240;',\n",
        " u'RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;',\n",
        " u'RT   \"A probability-based approach for high-throughput protein',\n",
        " u'RT   phosphorylation analysis and site localization.\";',\n",
        " u'RL   Nat. Biotechnol. 24:1285-1292(2006).',\n",
        " u'RN   [14]',\n",
        " u'RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].',\n",
        " u'RC   TISSUE=Cervix carcinoma;',\n",
        " u'RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;',\n",
        " u'RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,',\n",
        " u'RA   Greff Z., Keri G., Stemmann O., Mann M.;',\n",
        " u'RT   \"Kinase-selective enrichment enables quantitative phosphoproteomics of',\n",
        " u'RT   the kinome across the cell cycle.\";',\n",
        " u'RL   Mol. Cell 31:438-448(2008).',\n",
        " u'RN   [15]',\n",
        " u'RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401; SER-446; SER-447',\n",
        " u'RP   AND SER-729, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE',\n",
        " u'RP   ANALYSIS].',\n",
        " u'RC   TISSUE=Cervix carcinoma;',\n",
        " u'RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;',\n",
        " u'RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,',\n",
        " u'RA   Elledge S.J., Gygi S.P.;',\n",
        " u'RT   \"A quantitative atlas of mitotic phosphorylation.\";',\n",
        " u'RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).',\n",
        " u'RN   [16]',\n",
        " u'RP   SUBUNIT, INTERACTION WITH DGKH, AND PHOSPHORYLATION AT THR-753 BY',\n",
        " u'RP   MAPK1.',\n",
        " u'RX   PubMed=19710016; DOI=10.1074/jbc.M109.043604;',\n",
        " u'RA   Yasuda S., Kai M., Imai S., Takeishi K., Taketomi A., Toyota M.,',\n",
        " u'RA   Kanoh H., Sakane F.;',\n",
        " u'RT   \"Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf',\n",
        " u'RT   heterodimerization.\";',\n",
        " u'RL   J. Biol. Chem. 284:29559-29570(2009).',\n",
        " u'RN   [17]',\n",
        " u'RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].',\n",
        " u'RC   TISSUE=Leukemic T-cell;',\n",
        " u'RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;',\n",
        " u'RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,',\n",
        " u'RA   Rodionov V., Han D.K.;',\n",
        " u'RT   \"Quantitative phosphoproteomic analysis of T cell receptor signaling',\n",
        " u'RT   reveals system-wide modulation of protein-protein interactions.\";',\n",
        " u'RL   Sci. Signal. 2:RA46-RA46(2009).',\n",
        " u'RN   [18]',\n",
        " u'RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].',\n",
        " u'RC   TISSUE=Cervix carcinoma;',\n",
        " u'RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;',\n",
        " u'RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,',\n",
        " u'RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,',\n",
        " u'RA   Mann M.;',\n",
        " u'RT   \"Quantitative phosphoproteomics reveals widespread full',\n",
        " u'RT   phosphorylation site occupancy during mitosis.\";',\n",
        " u'RL   Sci. Signal. 3:RA3-RA3(2010).',\n",
        " u'RN   [19]',\n",
        " u'RP   INTERACTION WITH KSR2, SUBUNIT, CATALYTIC ACTIVITY, FUNCTION, AND',\n",
        " u'RP   MUTAGENESIS OF LYS-483.',\n",
        " u'RX   PubMed=21441910; DOI=10.1038/nature09860;',\n",
        " u'RA   Brennan D.F., Dar A.C., Hertz N.T., Chao W.C., Burlingame A.L.,',\n",
        " u'RA   Shokat K.M., Barford D.;',\n",
        " u'RT   \"A Raf-induced allosteric transition of KSR stimulates phosphorylation',\n",
        " u'RT   of MEK.\";',\n",
        " u'RL   Nature 472:366-369(2011).',\n",
        " u'RN   [20]',\n",
        " u'RP   INTERACTION WITH PRMT5, METHYLATION AT ARG-671, CHARACTERIZATION OF',\n",
        " u'RP   VARIANT CRC GLU-600, AND MUTAGENESIS OF ARG-671.',\n",
        " u'RX   PubMed=21917714; DOI=10.1126/scisignal.2001936;',\n",
        " u'RA   Andreu-Perez P., Esteve-Puig R., de Torre-Minguela C.,',\n",
        " u'RA   Lopez-Fauqued M., Bech-Serra J.J., Tenbaum S., Garcia-Trevijano E.R.,',\n",
        " u'RA   Canals F., Merlino G., Avila M.A., Recio J.A.;',\n",
        " u'RT   \"Protein arginine methyltransferase 5 regulates ERK1/2 signal',\n",
        " u'RT   transduction amplitude and cell fate through CRAF.\";',\n",
        " u'RL   Sci. Signal. 4:RA58-RA58(2011).',\n",
        " u'RN   [21]',\n",
        " u'RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729, AND IDENTIFICATION',\n",
        " u'RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].',\n",
        " u'RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;',\n",
        " u'RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,',\n",
        " u'RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,',\n",
        " u'RA   Blagoev B.;',\n",
        " u'RT   \"System-wide temporal characterization of the proteome and',\n",
        " u'RT   phosphoproteome of human embryonic stem cell differentiation.\";',\n",
        " u'RL   Sci. Signal. 4:RS3-RS3(2011).',\n",
        " u'RN   [22]',\n",
        " u'RP   UBIQUITINATION BY RNF149.',\n",
        " u'RX   PubMed=22628551; DOI=10.1074/jbc.M111.319822;',\n",
        " u'RA   Hong S.W., Jin D.H., Shin J.S., Moon J.H., Na Y.S., Jung K.A.,',\n",
        " u'RA   Kim S.M., Kim J.C., Kim K.P., Hong Y.S., Lee J.L., Choi E.K.,',\n",
        " u'RA   Lee J.S., Kim T.W.;',\n",
        " u'RT   \"Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type',\n",
        " u'RT   v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).\";',\n",
        " u'RL   J. Biol. Chem. 287:24017-24025(2012).',\n",
        " u'RN   [23]',\n",
        " u'RP   UBIQUITINATION AT LYS-578, AND MUTAGENESIS OF LYS-578.',\n",
        " u'RX   PubMed=23907581; DOI=10.1038/srep02344;',\n",
        " u'RA   An L., Jia W., Yu Y., Zou N., Liang L., Zhao Y., Fan Y., Cheng J.,',\n",
        " u'RA   Shi Z., Xu G., Li G., Yang J., Zhang H.;',\n",
        " u'RT   \"Lys63-linked polyubiquitination of BRAF at lysine 578 is required for',\n",
        " u'RT   BRAF-mediated signaling.\";',\n",
        " u'RL   Sci. Rep. 3:2344-2344(2013).',\n",
        " u'RN   [24]',\n",
        " u'RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 444-719 IN COMPLEX WITH',\n",
        " u'RP   INHIBITOR.',\n",
        " u'RX   PubMed=18287029; DOI=10.1073/pnas.0711741105;',\n",
        " u'RA   Tsai J., Lee J.T., Wang W., Zhang J., Cho H., Mamo S., Bremer R.,',\n",
        " u'RA   Gillette S., Kong J., Haass N.K., Sproesser K., Li L., Smalley K.S.,',\n",
        " u'RA   Fong D., Zhu Y.L., Marimuthu A., Nguyen H., Lam B., Liu J., Cheung I.,',\n",
        " u'RA   Rice J., Suzuki Y., Luu C., Settachatgul C., Shellooe R., Cantwell J.,',\n",
        " u'RA   Kim S.H., Schlessinger J., Zhang K.Y., West B.L., Powell B.,',\n",
        " u'RA   Habets G., Zhang C., Ibrahim P.N., Hirth P., Artis D.R., Herlyn M.,',\n",
        " u'RA   Bollag G.;',\n",
        " u'RT   \"Discovery of a selective inhibitor of oncogenic B-Raf kinase with',\n",
        " u'RT   potent antimelanoma activity.\";',\n",
        " u'RL   Proc. Natl. Acad. Sci. U.S.A. 105:3041-3046(2008).',\n",
        " u'RN   [25]',\n",
        " u'RP   VARIANTS LNCR VAL-466 AND ARG-597.',\n",
        " u'RX   PubMed=12460919;',\n",
        " u'RA   Naoki K., Chen T.-H., Richards W.G., Sugarbaker D.J., Meyerson M.;',\n",
        " u'RT   \"Missense mutations of the BRAF gene in human lung adenocarcinoma.\";',\n",
        " u'RL   Cancer Res. 62:7001-7003(2002).',\n",
        " u'RN   [26]',\n",
        " u'RP   VARIANTS CANCER GLU-464; VAL-464; ALA-466; GLU-466; VAL-466; ALA-469;',\n",
        " u'RP   GLU-469; LYS-586; LEU-595; ARG-596; ARG-597; VAL-597; GLU-600 AND',\n",
        " u'RP   ASP-600, AND CHARACTERIZATION OF VARIANTS CANCER VAL-464; ALA-469;',\n",
        " u'RP   VAL-597 AND GLU-600.',\n",
        " u'RX   PubMed=12068308; DOI=10.1038/nature00766;',\n",
        " u'RA   Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S.,',\n",
        " u'RA   Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N.,',\n",
        " u'RA   Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J.,',\n",
        " u'RA   Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S.,',\n",
        " u'RA   Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C.,',\n",
        " u'RA   Shipley J., Hargrave D., Pritchard-Jones K., Maitland N.,',\n",
        " u'RA   Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A.,',\n",
        " u'RA   Flanagan A., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T.,',\n",
        " u'RA   Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R.,',\n",
        " u'RA   Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.;',\n",
        " u'RT   \"Mutations of the BRAF gene in human cancer.\";',\n",
        " u'RL   Nature 417:949-954(2002).',\n",
        " u'RN   [27]',\n",
        " u'RP   VARIANTS CRC ILE-462; SER-463; GLU-464; GLU-600 AND GLU-601.',\n",
        " u'RX   PubMed=12198537; DOI=10.1038/418934a;',\n",
        " u'RA   Rajagopalan H., Bardelli A., Lengauer C., Kinzler K.W., Vogelstein B.,',\n",
        " u'RA   Velculescu V.E.;',\n",
        " u'RT   \"Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.\";',\n",
        " u'RL   Nature 418:934-934(2002).',\n",
        " u'RN   [28]',\n",
        " u'RP   VARIANTS NHL ALA-469; ARG-469 AND GLY-594.',\n",
        " u'RX   PubMed=14612909; DOI=10.1038/sj.bjc.6601371;',\n",
        " u'RA   Lee J.W., Yoo N.J., Soung Ark W.S., Kim S.Y., Lee J.H., Park J.Y.,',\n",
        " u'RA   Cho Y.G., Kim C.J., Ko Y.H., Kim S.H., Nam S.W., Lee J.Y., Lee S.H.;',\n",
        " u'RT   \"BRAF mutations in non-Hodgkin\\'s lymphoma.\";',\n",
        " u'RL   Br. J. Cancer 89:1958-1960(2003).',\n",
        " u'RN   [29]',\n",
        " u'RP   CHARACTERIZATION OF VARIANT MELANOMA GLU-600.',\n",
        " u'RX   PubMed=14500344;',\n",
        " u'RA   Hingorani S.R., Jacobetz M.A., Robertson G.P., Herlyn M.,',\n",
        " u'RA   Tuveson D.A.;',\n",
        " u'RT   \"Suppression of BRAF(V599E) in human melanoma abrogates',\n",
        " u'RT   transformation.\";',\n",
        " u'RL   Cancer Res. 63:5198-5202(2003).',\n",
        " u'RN   [30]',\n",
        " u'RP   VARIANTS CFC1 PRO-246; ARG-257; GLU-469; PHE-485; GLU-499; LYS-501;',\n",
        " u'RP   GLY-501 AND ASP-581.',\n",
        " u'RX   PubMed=16474404; DOI=10.1038/ng1749;',\n",
        " u'RA   Niihori T., Aoki Y., Narumi Y., Neri G., Cave H., Verloes A.,',\n",
        " u'RA   Okamoto N., Hennekam R.C.M., Gillessen-Kaesbach G., Wieczorek D.,',\n",
        " u'RA   Kavamura M.I., Kurosawa K., Ohashi H., Wilson L., Heron D.,',\n",
        " u'RA   Bonneau D., Corona G., Kaname T., Naritomi K., Baumann C.,',\n",
        " u'RA   Matsumoto N., Kato K., Kure S., Matsubara Y.;',\n",
        " u'RT   \"Germline KRAS and BRAF mutations in cardio-facio-cutaneous',\n",
        " u'RT   syndrome.\";',\n",
        " u'RL   Nat. Genet. 38:294-296(2006).',\n",
        " u'RN   [31]',\n",
        " u'RP   VARIANT [LARGE SCALE ANALYSIS] GLU-600.',\n",
        " u'RX   PubMed=16959974; DOI=10.1126/science.1133427;',\n",
        " u'RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,',\n",
        " u'RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,',\n",
        " u'RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,',\n",
        " u'RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,',\n",
        " u'RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,',\n",
        " u'RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;',\n",
        " u'RT   \"The consensus coding sequences of human breast and colorectal',\n",
        " u'RT   cancers.\";',\n",
        " u'RL   Science 314:268-274(2006).',\n",
        " u'RN   [32]',\n",
        " u'RP   VARIANTS CFC1 ARG-257; ALA-467; SER-468; GLU-469; PHE-485; GLU-499;',\n",
        " u'RP   LYS-501; GLY-501; ASP-581; LEU-595 AND VAL-596.',\n",
        " u'RX   PubMed=16439621; DOI=10.1126/science.1124642;',\n",
        " u'RA   Rodriguez-Viciana P., Tetsu O., Tidyman W.E., Estep A.L., Conger B.A.,',\n",
        " u'RA   Cruz M.S., McCormick F., Rauen K.A.;',\n",
        " u'RT   \"Germline mutations in genes within the MAPK pathway cause cardio-',\n",
        " u'RT   facio-cutaneous syndrome.\";',\n",
        " u'RL   Science 311:1287-1290(2006).',\n",
        " u'RN   [33]',\n",
        " u'RP   VARIANTS [LARGE SCALE ANALYSIS] SER-301; ALA-469; VAL-469; SER-581;',\n",
        " u'RP   ARG-596; ARG-597; VAL-597; GLU-600; GLU-600 AND GLU-600.',\n",
        " u'RX   PubMed=17344846; DOI=10.1038/nature05610;',\n",
        " u'RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,',\n",
        " u'RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,',\n",
        " u\"RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,\",\n",
        " u'RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,',\n",
        " u'RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,',\n",
        " u'RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,',\n",
        " u'RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,',\n",
        " u'RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,',\n",
        " u'RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,',\n",
        " u'RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,',\n",
        " u'RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,',\n",
        " u'RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;',\n",
        " u'RT   \"Patterns of somatic mutation in human cancer genomes.\";',\n",
        " u'RL   Nature 446:153-158(2007).',\n",
        " u'RN   [34]',\n",
        " u'RP   VARIANTS CFC1 PRO-241; PRO-244; PRO-246; ARG-257; LYS-262; SER-468;',\n",
        " u'RP   GLU-469; GLU-499; ASN-499; ASP-580; ASP-581 AND LEU-595.',\n",
        " u'RX   PubMed=18042262; DOI=10.1111/j.1399-0004.2007.00931.x;',\n",
        " u'RA   Schulz A.L., Albrecht B., Arici C., van der Burgt I., Buske A.,',\n",
        " u'RA   Gillessen-Kaesbach G., Heller R., Horn D., Hubner C.A., Korenke G.C.,',\n",
        " u'RA   Konig R., Kress W., Kruger G., Meinecke P., Mucke J., Plecko B.,',\n",
        " u'RA   Rossier E., Schinzel A., Schulze A., Seemanova E., Seidel H.,',\n",
        " u'RA   Spranger S., Tuysuz B., Uhrig S., Wieczorek D., Kutsche K., Zenker M.;',\n",
        " u'RT   \"Mutation and phenotypic spectrum in patients with cardio-facio-',\n",
        " u'RT   cutaneous and Costello syndrome.\";',\n",
        " u'RL   Clin. Genet. 73:62-70(2008).',\n",
        " u'RN   [35]',\n",
        " u'RP   VARIANT LEOPARD3 PRO-241, VARIANTS NS7 CYS-531 AND VAL-597, VARIANTS',\n",
        " u'RP   CFC1 PHE-245; PRO-246; ARG-257; LYS-275; GLU-469; PHE-485; ASN-499;',\n",
        " u'RP   LYS-501; PRO-525; LEU-595; ARG-599; GLN-601; GLU-638 AND ARG-709, AND',\n",
        " u'RP   VARIANTS ARG-241 AND MET-241.',\n",
        " u'RX   PubMed=19206169; DOI=10.1002/humu.20955;',\n",
        " u'RA   Sarkozy A., Carta C., Moretti S., Zampino G., Digilio M.C.,',\n",
        " u'RA   Pantaleoni F., Scioletti A.P., Esposito G., Cordeddu V., Lepri F.,',\n",
        " u'RA   Petrangeli V., Dentici M.L., Mancini G.M., Selicorni A., Rossi C.,',\n",
        " u'RA   Mazzanti L., Marino B., Ferrero G.B., Silengo M.C., Memo L.,',\n",
        " u'RA   Stanzial F., Faravelli F., Stuppia L., Puxeddu E., Gelb B.D.,',\n",
        " u'RA   Dallapiccola B., Tartaglia M.;',\n",
        " u'RT   \"Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous',\n",
        " u'RT   syndromes: molecular diversity and associated phenotypic spectrum.\";',\n",
        " u'RL   Hum. Mutat. 30:695-702(2009).',\n",
        " u'RN   [36]',\n",
        " u'RP   VARIANT CRC GLU-600.',\n",
        " u'RX   PubMed=23263490; DOI=10.1038/ng.2503;',\n",
        " u'RG   CORGI Consortium;',\n",
        " u'RG   WGS500 Consortium;',\n",
        " u'RA   Palles C., Cazier J.B., Howarth K.M., Domingo E., Jones A.M.,',\n",
        " u'RA   Broderick P., Kemp Z., Spain S.L., Guarino Almeida E., Salguero I.,',\n",
        " u'RA   Sherborne A., Chubb D., Carvajal-Carmona L.G., Ma Y., Kaur K.,',\n",
        " u'RA   Dobbins S., Barclay E., Gorman M., Martin L., Kovac M.B., Humphray S.,',\n",
        " u'RA   Lucassen A., Holmes C.C., Bentley D., Donnelly P., Taylor J.,',\n",
        " u'RA   Petridis C., Roylance R., Sawyer E.J., Kerr D.J., Clark S., Grimes J.,',\n",
        " u'RA   Kearsey S.E., Thomas H.J., McVean G., Houlston R.S., Tomlinson I.;',\n",
        " u'RT   \"Germline mutations affecting the proofreading domains of POLE and',\n",
        " u'RT   POLD1 predispose to colorectal adenomas and carcinomas.\";',\n",
        " u'RL   Nat. Genet. 45:136-144(2013).',\n",
        " u'CC   -!- FUNCTION: Protein kinase involved in the transduction of mitogenic',\n",
        " u'CC       signals from the cell membrane to the nucleus. May play a role in',\n",
        " u'CC       the postsynaptic responses of hippocampal neuron. Phosphorylates',\n",
        " u'CC       MAP2K1, and thereby contributes to the MAP kinase signal',\n",
        " u'CC       transduction pathway.',\n",
        " u'CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.',\n",
        " u'CC   -!- COFACTOR: Binds 2 zinc ions per subunit (By similarity).',\n",
        " u'CC   -!- ENZYME REGULATION: Activity is increased by EGF and HGF.',\n",
        " u'CC   -!- SUBUNIT: Monomer. Homodimer. Heterodimerizes with RAF1, and the',\n",
        " u'CC       heterodimer possesses a highly increased kinase activity compared',\n",
        " u'CC       to the respective homodimers or monomers. Heterodimerization is',\n",
        " u'CC       mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2',\n",
        " u'CC       activation can induce a negative feedback that promotes the',\n",
        " u'CC       dissociation of the heterodimer by phosphorylating BRAF at Thr-',\n",
        " u'CC       753. Found in a complex with at least BRAF, HRAS, MAP2K1, MAPK3',\n",
        " u'CC       and RGS14. Interacts with RIT1. Interacts (via N-terminus) with',\n",
        " u'CC       RGS14 (via RBD domains); the interaction mediates the formation of',\n",
        " u'CC       a ternary complex with RAF1, a ternary complex inhibited by GNAI1',\n",
        " u'CC       (By similarity). Interacts with DGKH. Interacts with PRMT5.',\n",
        " u'CC       Interacts with KSR2.',\n",
        " u'CC   -!- INTERACTION:',\n",
        " u'CC       Self; NbExp=8; IntAct=EBI-365980, EBI-365980;',\n",
        " u'CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-365980, EBI-352572;',\n",
        " u'CC       Q61097:Ksr1 (xeno); NbExp=3; IntAct=EBI-365980, EBI-1536336;',\n",
        " u'CC       Q13233:MAP3K1; NbExp=2; IntAct=EBI-365980, EBI-49776;',\n",
        " u'CC       P04049:RAF1; NbExp=39; IntAct=EBI-365980, EBI-365996;',\n",
        " u'CC       Q99N57:Raf1 (xeno); NbExp=3; IntAct=EBI-365980, EBI-397757;',\n",
        " u'CC       Q8CGE9:Rgs12 (xeno); NbExp=2; IntAct=EBI-365980, EBI-7340552;',\n",
        " u'CC       Q15349:RPS6KA2; NbExp=2; IntAct=EBI-365980, EBI-1384149;',\n",
        " u'CC       Q13114:TRAF3; NbExp=2; IntAct=EBI-365980, EBI-357631;',\n",
        " u'CC       P31946:YWHAB; NbExp=3; IntAct=EBI-365980, EBI-359815;',\n",
        " u'CC       P63104:YWHAZ; NbExp=3; IntAct=EBI-365980, EBI-347088;',\n",
        " u'CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity). Cytoplasm. Cell',\n",
        " u'CC       membrane (By similarity). Note=Colocalizes with RGS14 and RAF1 in',\n",
        " u'CC       both the cytoplasm and membranes (By similarity).',\n",
        " u'CC   -!- TISSUE SPECIFICITY: Brain and testis.',\n",
        " u'CC   -!- PTM: Phosphorylation at Ser-365 by SGK1 inhibits its activity.',\n",
        " u'CC   -!- PTM: Methylation at Arg-671 decreases stability and kinase',\n",
        " u'CC       activity.',\n",
        " u'CC   -!- PTM: Ubiquitinated by RNF149; which leads to proteasomal',\n",
        " u'CC       degradation. Polyubiquitinated at Lys-578 in response to EGF.',\n",
        " u'CC   -!- DISEASE: Note=Defects in BRAF are found in a wide range of',\n",
        " u'CC       cancers.',\n",
        " u'CC   -!- DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease',\n",
        " u'CC       characterized by malignant lesions arising from the inner wall of',\n",
        " u'CC       the large intestine (the colon) and the rectum. Genetic',\n",
        " u'CC       alterations are often associated with progression from',\n",
        " u'CC       premalignant lesion (adenoma) to invasive adenocarcinoma. Risk',\n",
        " u'CC       factors for cancer of the colon and rectum include colon polyps,',\n",
        " u'CC       long-standing ulcerative colitis, and genetic family history.',\n",
        " u'CC       Note=The disease may be caused by mutations affecting the gene',\n",
        " u'CC       represented in this entry.',\n",
        " u'CC   -!- DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy',\n",
        " u'CC       affecting tissues of the lung. The most common form of lung cancer',\n",
        " u'CC       is non-small cell lung cancer (NSCLC) that can be divided into 3',\n",
        " u'CC       major histologic subtypes: squamous cell carcinoma,',\n",
        " u'CC       adenocarcinoma, and large cell lung cancer. NSCLC is often',\n",
        " u'CC       diagnosed at an advanced stage and has a poor prognosis. Note=The',\n",
        " u'CC       gene represented in this entry is involved in disease',\n",
        " u'CC       pathogenesis.',\n",
        " u'CC   -!- DISEASE: Familial non-Hodgkin lymphoma (NHL) [MIM:605027]: Cancer',\n",
        " u'CC       that starts in cells of the lymph system, which is part of the',\n",
        " u\"CC       body's immune system. NHLs can occur at any age and are often\",\n",
        " u'CC       marked by enlarged lymph nodes, fever and weight loss. Note=The',\n",
        " u'CC       gene represented in this entry is involved in disease',\n",
        " u'CC       pathogenesis.',\n",
        " u'CC   -!- DISEASE: Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]: A',\n",
        " u'CC       multiple congenital anomaly disorder characterized by a',\n",
        " u'CC       distinctive facial appearance, heart defects and mental',\n",
        " u'CC       retardation. Heart defects include pulmonic stenosis, atrial',\n",
        " u'CC       septal defects and hypertrophic cardiomyopathy. Some affected',\n",
        " u'CC       individuals present with ectodermal abnormalities such as sparse,',\n",
        " u'CC       friable hair, hyperkeratotic skin lesions and a generalized',\n",
        " u'CC       ichthyosis-like condition. Typical facial features are similar to',\n",
        " u'CC       Noonan syndrome. They include high forehead with bitemporal',\n",
        " u'CC       constriction, hypoplastic supraorbital ridges, downslanting',\n",
        " u'CC       palpebral fissures, a depressed nasal bridge, and posteriorly',\n",
        " u'CC       angulated ears with prominent helices. Note=The disease is caused',\n",
        " u'CC       by mutations affecting the gene represented in this entry.',\n",
        " u'CC   -!- DISEASE: Noonan syndrome 7 (NS7) [MIM:613706]: A form of Noonan',\n",
        " u'CC       syndrome, a disease characterized by short stature, facial',\n",
        " u'CC       dysmorphic features such as hypertelorism, a downward eyeslant and',\n",
        " u'CC       low-set posteriorly rotated ears, and a high incidence of',\n",
        " u'CC       congenital heart defects and hypertrophic cardiomyopathy. Other',\n",
        " u'CC       features can include a short neck with webbing or redundancy of',\n",
        " u'CC       skin, deafness, motor delay, variable intellectual deficits,',\n",
        " u'CC       multiple skeletal defects, cryptorchidism, and bleeding diathesis.',\n",
        " u'CC       Individuals with Noonan syndrome are at risk of juvenile',\n",
        " u'CC       myelomonocytic leukemia, a myeloproliferative disorder',\n",
        " u'CC       characterized by excessive production of myelomonocytic cells.',\n",
        " u'CC       Note=The disease is caused by mutations affecting the gene',\n",
        " u'CC       represented in this entry.',\n",
        " u'CC   -!- DISEASE: LEOPARD syndrome 3 (LEOPARD3) [MIM:613707]: A disorder',\n",
        " u'CC       characterized by lentigines, electrocardiographic conduction',\n",
        " u'CC       abnormalities, ocular hypertelorism, pulmonic stenosis,',\n",
        " u'CC       abnormalities of genitalia, retardation of growth, and',\n",
        " u'CC       sensorineural deafness. Note=The disease is caused by mutations',\n",
        " u'CC       affecting the gene represented in this entry.',\n",
        " u'CC   -!- DISEASE: Note=A chromosomal aberration involving BRAF is found in',\n",
        " u'CC       pilocytic astrocytomas. A tandem duplication of 2 Mb at 7q34 leads',\n",
        " u'CC       to the expression of a KIAA1549-BRAF fusion protein with a',\n",
        " u'CC       constitutive kinase activity and inducing cell transformation.',\n",
        " u'CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr',\n",
        " u'CC       protein kinase family. RAF subfamily.',\n",
        " u'CC   -!- SIMILARITY: Contains 1 phorbol-ester/DAG-type zinc finger.',\n",
        " u'CC   -!- SIMILARITY: Contains 1 protein kinase domain.',\n",
        " u'CC   -!- SIMILARITY: Contains 1 RBD (Ras-binding) domain.',\n",
        " u'CC   -!- SEQUENCE CAUTION:',\n",
        " u'CC       Sequence=AAD43193.1; Type=Erroneous gene model prediction;',\n",
        " u'CC       Sequence=CAQ43111.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;',\n",
        " u'CC       Sequence=CAQ43112.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;',\n",
        " u'CC       Sequence=CAQ43113.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;',\n",
        " u'CC       Sequence=CAQ43114.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;',\n",
        " u'CC       Sequence=CAQ43115.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;',\n",
        " u'CC       Sequence=CAQ43116.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;',\n",
        " u'CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology',\n",
        " u'CC       and Haematology;',\n",
        " u'CC       URL=\"http://atlasgeneticsoncology.org/Genes/BRAFID828.html\";',\n",
        " u'CC   -----------------------------------------------------------------------',\n",
        " u'CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms',\n",
        " u'CC   Distributed under the Creative Commons Attribution-NoDerivs License',\n",
        " u'CC   -----------------------------------------------------------------------',\n",
        " u'DR   EMBL; M95712; AAA35609.2; -; mRNA.',\n",
        " u'DR   EMBL; AC006344; AAD43193.1; ALT_SEQ; Genomic_DNA.',\n",
        " u'DR   EMBL; EU600171; ACD11489.1; -; Genomic_DNA.',\n",
        " u'DR   EMBL; AC006347; AAD15551.1; -; Genomic_DNA.',\n",
        " u'DR   EMBL; CH236950; EAL24023.1; -; Genomic_DNA.',\n",
        " u'DR   EMBL; BC101757; AAI01758.1; -; mRNA.',\n",
        " u'DR   EMBL; BC112079; AAI12080.1; -; mRNA.',\n",
        " u'DR   EMBL; X65187; CAA46301.1; -; Genomic_DNA.',\n",
        " u'DR   EMBL; M21001; AAA96495.1; -; mRNA.',\n",
        " u'DR   EMBL; AM989472; CAQ43111.1; ALT_INIT; mRNA.',\n",
        " u'DR   EMBL; AM989473; CAQ43112.1; ALT_INIT; mRNA.',\n",
        " u'DR   EMBL; AM989474; CAQ43113.1; ALT_INIT; mRNA.',\n",
        " u'DR   EMBL; AM989475; CAQ43114.1; ALT_INIT; mRNA.',\n",
        " u'DR   EMBL; AM989476; CAQ43115.1; ALT_INIT; mRNA.',\n",
        " u'DR   EMBL; AM989477; CAQ43116.1; ALT_INIT; mRNA.',\n",
        " u'DR   CCDS; CCDS5863.1; -.',\n",
        " u'DR   PIR; A57977; TVHUBF.',\n",
        " u'DR   RefSeq; NP_004324.2; NM_004333.4.',\n",
        " u'DR   UniGene; Hs.550061; -.',\n",
        " u'DR   UniGene; Hs.600998; -.',\n",
        " u'DR   UniGene; Hs.605380; -.',\n",
        " u'DR   UniGene; Hs.659507; -.',\n",
        " u'DR   PDB; 1UWH; X-ray; 2.95 A; A/B=448-723.',\n",
        " u'DR   PDB; 1UWJ; X-ray; 3.50 A; A/B=448-723.',\n",
        " u'DR   PDB; 2FB8; X-ray; 2.90 A; A/B=445-723.',\n",
        " u'DR   PDB; 2L05; NMR; -; A=149-232.',\n",
        " u'DR   PDB; 3C4C; X-ray; 2.57 A; A/B=444-721.',\n",
        " u'DR   PDB; 3D4Q; X-ray; 2.80 A; A/B=433-726.',\n",
        " u'DR   PDB; 3IDP; X-ray; 2.70 A; A/B=434-727.',\n",
        " u'DR   PDB; 3II5; X-ray; 2.79 A; A/B=432-726.',\n",
        " u'DR   PDB; 3NY5; X-ray; 1.99 A; A/B/C/D=153-237.',\n",
        " u'DR   PDB; 3OG7; X-ray; 2.45 A; A/B=449-766.',\n",
        " u'DR   PDB; 3PPJ; X-ray; 3.70 A; A/B=432-726.',\n",
        " u'DR   PDB; 3PPK; X-ray; 3.00 A; A/B=432-726.',\n",
        " u'DR   PDB; 3PRF; X-ray; 2.90 A; A/B=432-726.',\n",
        " u'DR   PDB; 3PRI; X-ray; 3.50 A; A/B=432-726.',\n",
        " u'DR   PDB; 3PSB; X-ray; 3.40 A; A/B=433-726.',\n",
        " u'DR   PDB; 3PSD; X-ray; 3.60 A; A/B=433-726.',\n",
        " u'DR   PDB; 3Q4C; X-ray; 3.20 A; A/B=432-726.',\n",
        " u'DR   PDB; 3Q96; X-ray; 3.10 A; A/B=446-727.',\n",
        " u'DR   PDB; 3SKC; X-ray; 3.20 A; A/B=432-726.',\n",
        " u'DR   PDB; 3TV4; X-ray; 3.40 A; A/B=432-726.',\n",
        " u'DR   PDB; 3TV6; X-ray; 3.30 A; A/B=432-726.',\n",
        " u'DR   PDB; 4DBN; X-ray; 3.15 A; A/B=445-726.',\n",
        " u'DR   PDB; 4E26; X-ray; 2.55 A; A/B=432-726.',\n",
        " u'DR   PDB; 4E4X; X-ray; 3.60 A; A/B=432-726.',\n",
        " u'DR   PDB; 4EHE; X-ray; 3.30 A; A/B=432-726.',\n",
        " u'DR   PDB; 4EHG; X-ray; 3.50 A; A/B=432-726.',\n",
        " u'DR   PDB; 4FC0; X-ray; 2.95 A; A/B=445-726.',\n",
        " u'DR   PDB; 4FK3; X-ray; 2.65 A; A/B=444-723.',\n",
        " u'DR   PDB; 4G9C; X-ray; 3.50 A; A/B=432-726.',\n",
        " u'DR   PDB; 4G9R; X-ray; 3.20 A; A/B=432-726.',\n",
        " u'DR   PDB; 4H58; X-ray; 3.10 A; A/B/C=448-722.',\n",
        " u'DR   PDB; 4JVG; X-ray; 3.09 A; A/B/C/D=444-723.',\n",
        " u'DR   PDB; 4KSP; X-ray; 2.93 A; A/B=445-726.',\n",
        " u'DR   PDB; 4KSQ; X-ray; 3.30 A; A/B=445-726.',\n",
        " u'DR   PDB; 4MBJ; X-ray; 3.60 A; A/B=432-723.',\n",
        " u'DR   PDB; 4PP7; X-ray; 3.40 A; A/B=432-726.',\n",
        " u'DR   PDBsum; 1UWH; -.',\n",
        " u'DR   PDBsum; 1UWJ; -.',\n",
        " u'DR   PDBsum; 2FB8; -.',\n",
        " u'DR   PDBsum; 2L05; -.',\n",
        " u'DR   PDBsum; 3C4C; -.',\n",
        " u'DR   PDBsum; 3D4Q; -.',\n",
        " u'DR   PDBsum; 3IDP; -.',\n",
        " u'DR   PDBsum; 3II5; -.',\n",
        " u'DR   PDBsum; 3NY5; -.',\n",
        " u'DR   PDBsum; 3OG7; -.',\n",
        " u'DR   PDBsum; 3PPJ; -.',\n",
        " u'DR   PDBsum; 3PPK; -.',\n",
        " u'DR   PDBsum; 3PRF; -.',\n",
        " u'DR   PDBsum; 3PRI; -.',\n",
        " u'DR   PDBsum; 3PSB; -.',\n",
        " u'DR   PDBsum; 3PSD; -.',\n",
        " u'DR   PDBsum; 3Q4C; -.',\n",
        " u'DR   PDBsum; 3Q96; -.',\n",
        " u'DR   PDBsum; 3SKC; -.',\n",
        " u'DR   PDBsum; 3TV4; -.',\n",
        " u'DR   PDBsum; 3TV6; -.',\n",
        " u'DR   PDBsum; 4DBN; -.',\n",
        " u'DR   PDBsum; 4E26; -.',\n",
        " u'DR   PDBsum; 4E4X; -.',\n",
        " u'DR   PDBsum; 4EHE; -.',\n",
        " u'DR   PDBsum; 4EHG; -.',\n",
        " u'DR   PDBsum; 4FC0; -.',\n",
        " u'DR   PDBsum; 4FK3; -.',\n",
        " u'DR   PDBsum; 4G9C; -.',\n",
        " u'DR   PDBsum; 4G9R; -.',\n",
        " u'DR   PDBsum; 4H58; -.',\n",
        " u'DR   PDBsum; 4JVG; -.',\n",
        " u'DR   PDBsum; 4KSP; -.',\n",
        " u'DR   PDBsum; 4KSQ; -.',\n",
        " u'DR   PDBsum; 4MBJ; -.',\n",
        " u'DR   PDBsum; 4PP7; -.',\n",
        " u'DR   ProteinModelPortal; P15056; -.',\n",
        " u'DR   SMR; P15056; 149-283, 448-723.',\n",
        " u'DR   BioGrid; 107141; 41.',\n",
        " u'DR   DIP; DIP-1045N; -.',\n",
        " u'DR   IntAct; P15056; 36.',\n",
        " u'DR   MINT; MINT-1574728; -.',\n",
        " u'DR   STRING; 9606.ENSP00000288602; -.',\n",
        " u'DR   BindingDB; P15056; -.',\n",
        " u'DR   ChEMBL; CHEMBL5145; -.',\n",
        " u'DR   DrugBank; DB00398; Sorafenib.',\n",
        " u'DR   GuidetoPHARMACOLOGY; 1943; -.',\n",
        " u'DR   PhosphoSite; P15056; -.',\n",
        " u'DR   DMDM; 50403720; -.',\n",
        " u'DR   MaxQB; P15056; -.',\n",
        " u'DR   PaxDb; P15056; -.',\n",
        " u'DR   PRIDE; P15056; -.',\n",
        " u'DR   DNASU; 673; -.',\n",
        " u'DR   Ensembl; ENST00000288602; ENSP00000288602; ENSG00000157764.',\n",
        " u'DR   GeneID; 673; -.',\n",
        " u'DR   KEGG; hsa:673; -.',\n",
        " u'DR   UCSC; uc003vwc.4; human.',\n",
        " u'DR   CTD; 673; -.',\n",
        " u'DR   GeneCards; GC07M140424; -.',\n",
        " u'DR   GeneReviews; BRAF; -.',\n",
        " u'DR   H-InvDB; HIX0167822; -.',\n",
        " u'DR   HGNC; HGNC:1097; BRAF.',\n",
        " u'DR   HPA; CAB004552; -.',\n",
        " u'DR   HPA; HPA001328; -.',\n",
        " u'DR   MIM; 114500; phenotype.',\n",
        " u'DR   MIM; 115150; phenotype.',\n",
        " u'DR   MIM; 164757; gene.',\n",
        " u'DR   MIM; 211980; phenotype.',\n",
        " u'DR   MIM; 605027; phenotype.',\n",
        " u'DR   MIM; 613706; phenotype.',\n",
        " u'DR   MIM; 613707; phenotype.',\n",
        " u'DR   neXtProt; NX_P15056; -.',\n",
        " u'DR   Orphanet; 1340; Cardiofaciocutaneous syndrome.',\n",
        " u'DR   Orphanet; 54595; Craniopharyngioma.',\n",
        " u'DR   Orphanet; 58017; Hairy cell leukemia.',\n",
        " u'DR   Orphanet; 99872; Hashimoto-Pritzker syndrome.',\n",
        " u'DR   Orphanet; 500; LEOPARD syndrome.',\n",
        " u'DR   Orphanet; 648; Noonan syndrome.',\n",
        " u'DR   Orphanet; 251612; Pilocytic astrocytoma.',\n",
        " u'DR   PharmGKB; PA25408; -.',\n",
        " u'DR   eggNOG; COG0515; -.',\n",
        " u'DR   HOVERGEN; HBG001886; -.',\n",
        " u'DR   InParanoid; P15056; -.',\n",
        " u'DR   KO; K04365; -.',\n",
        " u'DR   OMA; HRTRTSS; -.',\n",
        " u'DR   OrthoDB; EOG7F5128; -.',\n",
        " u'DR   PhylomeDB; P15056; -.',\n",
        " u'DR   TreeFam; TF317006; -.',\n",
        " u'DR   BRENDA; 2.7.10.2; 2681.',\n",
        " u'DR   Reactome; REACT_111102; Signal Transduction.',\n",
        " u'DR   Reactome; REACT_116125; Disease.',\n",
        " u'DR   Reactome; REACT_13685; Neuronal System.',\n",
        " u'DR   SignaLink; P15056; -.',\n",
        " u'DR   ChiTaRS; BRAF; human.',\n",
        " u'DR   EvolutionaryTrace; P15056; -.',\n",
        " u'DR   GeneWiki; BRAF_(gene); -.',\n",
        " u'DR   GenomeRNAi; 673; -.',\n",
        " u'DR   NextBio; 2776; -.',\n",
        " u'DR   PMAP-CutDB; P15056; -.',\n",
        " u'DR   PRO; PR:P15056; -.',\n",
        " u'DR   ArrayExpress; P15056; -.',\n",
        " u'DR   Bgee; P15056; -.',\n",
        " u'DR   CleanEx; HS_BRAF; -.',\n",
        " u'DR   Genevestigator; P15056; -.',\n",
        " u'DR   GO; GO:0005829; C:cytosol; TAS:Reactome.',\n",
        " u'DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.',\n",
        " u'DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.',\n",
        " u'DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.',\n",
        " u'DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.',\n",
        " u'DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.',\n",
        " u'DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.',\n",
        " u'DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IEA:Ensembl.',\n",
        " u'DR   GO; GO:0005515; F:protein binding; IPI:IntAct.',\n",
        " u'DR   GO; GO:0004672; F:protein kinase activity; IDA:BHF-UCL.',\n",
        " u'DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.',\n",
        " u'DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:Reactome.',\n",
        " u'DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:BHF-UCL.',\n",
        " u'DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.',\n",
        " u'DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.',\n",
        " u'DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.',\n",
        " u'DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome.',\n",
        " u'DR   GO; GO:0009887; P:organ morphogenesis; TAS:ProtInc.',\n",
        " u'DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL.',\n",
        " u'DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.',\n",
        " u'DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB.',\n",
        " u'DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.',\n",
        " u'DR   GO; GO:0006468; P:protein phosphorylation; IDA:BHF-UCL.',\n",
        " u'DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.',\n",
        " u'DR   GO; GO:0070849; P:response to epidermal growth factor; IDA:BHF-UCL.',\n",
        " u'DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.',\n",
        " u'DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome.',\n",
        " u'DR   GO; GO:0007268; P:synaptic transmission; TAS:Reactome.',\n",
        " u'DR   InterPro; IPR020454; DAG/PE-bd.',\n",
        " u'DR   InterPro; IPR011009; Kinase-like_dom.',\n",
        " u'DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.',\n",
        " u'DR   InterPro; IPR000719; Prot_kinase_dom.',\n",
        " u'DR   InterPro; IPR017441; Protein_kinase_ATP_BS.',\n",
        " u'DR   InterPro; IPR003116; Raf-like_ras-bd.',\n",
        " u'DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.',\n",
        " u'DR   InterPro; IPR008271; Ser/Thr_kinase_AS.',\n",
        " u'DR   InterPro; IPR029071; Ubiquitin-rel_dom.',\n",
        " u'DR   Pfam; PF00130; C1_1; 1.',\n",
        " u'DR   Pfam; PF07714; Pkinase_Tyr; 1.',\n",
        " u'DR   Pfam; PF02196; RBD; 1.',\n",
        " u'DR   PRINTS; PR00008; DAGPEDOMAIN.',\n",
        " u'DR   SMART; SM00109; C1; 1.',\n",
        " u'DR   SMART; SM00455; RBD; 1.',\n",
        " u'DR   SUPFAM; SSF54236; SSF54236; 1.',\n",
        " u'DR   SUPFAM; SSF56112; SSF56112; 1.',\n",
        " u'DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.',\n",
        " u'DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.',\n",
        " u'DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.',\n",
        " u'DR   PROSITE; PS50898; RBD; 1.',\n",
        " u'DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.',\n",
        " u'DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.',\n",
        " u'PE   1: Evidence at protein level;',\n",
        " u'KW   3D-structure; Acetylation; ATP-binding; Cardiomyopathy; Cell membrane;',\n",
        " u'KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Deafness;',\n",
        " u'KW   Direct protein sequencing; Disease mutation; Ectodermal dysplasia;',\n",
        " u'KW   Isopeptide bond; Kinase; Membrane; Mental retardation; Metal-binding;',\n",
        " u'KW   Methylation; Nucleotide-binding; Nucleus; Phosphoprotein;',\n",
        " u'KW   Polymorphism; Proto-oncogene; Reference proteome;',\n",
        " u'KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation; Zinc;',\n",
        " u'KW   Zinc-finger.',\n",
        " u'FT   INIT_MET      1      1       Removed.',\n",
        " u'FT   CHAIN         2    766       Serine/threonine-protein kinase B-raf.',\n",
        " u'FT                                /FTId=PRO_0000085665.',\n",
        " u'FT   DOMAIN      155    227       RBD.',\n",
        " u'FT   DOMAIN      457    717       Protein kinase.',\n",
        " u'FT   ZN_FING     234    280       Phorbol-ester/DAG-type.',\n",
        " u'FT   NP_BIND     463    471       ATP (By similarity).',\n",
        " u'FT   COMPBIAS      6     11       Poly-Gly.',\n",
        " u'FT   COMPBIAS    122    129       Poly-Ser.',\n",
        " u'FT   COMPBIAS    428    432       Poly-Ser.',\n",
        " u'FT   ACT_SITE    576    576       Proton acceptor (By similarity).',\n",
        " u'FT   METAL       235    235       Zinc 1 (By similarity).',\n",
        " u'FT   METAL       248    248       Zinc 2 (By similarity).',\n",
        " u'FT   METAL       251    251       Zinc 2 (By similarity).',\n",
        " u'FT   METAL       261    261       Zinc 1 (By similarity).',\n",
        " u'FT   METAL       264    264       Zinc 1 (By similarity).',\n",
        " u'FT   METAL       269    269       Zinc 2 (By similarity).',\n",
        " u'FT   METAL       272    272       Zinc 2 (By similarity).',\n",
        " u'FT   METAL       280    280       Zinc 1 (By similarity).',\n",
        " u'FT   BINDING     483    483       ATP (By similarity).',\n",
        " u'FT   SITE        380    381       Breakpoint for translocation to form',\n",
        " u'FT                                KIAA1549-BRAF fusion protein.',\n",
        " u'FT   SITE        438    439       Breakpoint for translocation to form',\n",
        " u'FT                                KIAA1549-BRAF fusion protein.',\n",
        " u'FT   MOD_RES       2      2       N-acetylalanine.',\n",
        " u'FT   MOD_RES     365    365       Phosphoserine; by SGK1.',\n",
        " u'FT   MOD_RES     373    373       Phosphothreonine; by autocatalysis.',\n",
        " u'FT   MOD_RES     396    396       Phosphothreonine.',\n",
        " u'FT   MOD_RES     399    399       Phosphoserine.',\n",
        " u'FT   MOD_RES     401    401       Phosphothreonine.',\n",
        " u'FT   MOD_RES     446    446       Phosphoserine.',\n",
        " u'FT   MOD_RES     447    447       Phosphoserine.',\n",
        " u'FT   MOD_RES     671    671       Omega-N-methylarginine; by PRMT5.',\n",
        " u'FT   MOD_RES     729    729       Phosphoserine.',\n",
        " u'FT   MOD_RES     753    753       Phosphothreonine; by MAPK1.',\n",
        " u'FT   CROSSLNK    578    578       Glycyl lysine isopeptide (Lys-Gly)',\n",
        " u'FT                                (interchain with G-Cter in ubiquitin).',\n",
        " u'FT   VARIANT     241    241       T -> M (in a patient with Noonan',\n",
        " u'FT                                syndrome).',\n",
        " u'FT                                /FTId=VAR_058620.',\n",
        " u'FT   VARIANT     241    241       T -> P (in CFC1 and LEOPARD3).',\n",
        " u'FT                                /FTId=VAR_058621.',\n",
        " u'FT   VARIANT     241    241       T -> R (in a patient with Noonan',\n",
        " u'FT                                syndrome).',\n",
        " u'FT                                /FTId=VAR_058622.',\n",
        " u'FT   VARIANT     244    244       T -> P (in CFC1).',\n",
        " u'FT                                /FTId=VAR_065171.',\n",
        " u'FT   VARIANT     245    245       L -> F (in CFC1).',\n",
        " u'FT                                /FTId=VAR_058623.',\n",
        " u'FT   VARIANT     246    246       A -> P (in CFC1).',\n",
        " u'FT                                /FTId=VAR_026113.',\n",
        " u'FT   VARIANT     257    257       Q -> R (in CFC1).',\n",
        " u'FT                                /FTId=VAR_026114.',\n",
        " u'FT   VARIANT     262    262       Q -> K (in CFC1).',\n",
        " u'FT                                /FTId=VAR_065172.',\n",
        " u'FT   VARIANT     275    275       E -> K (in CFC1).',\n",
        " u'FT                                /FTId=VAR_058624.',\n",
        " u'FT   VARIANT     301    301       P -> S (in dbSNP:rs34776339).',\n",
        " u'FT                                /FTId=VAR_040391.',\n",
        " u'FT   VARIANT     462    462       R -> I (in CRC).',\n",
        " u'FT                                /FTId=VAR_018613.',\n",
        " u'FT   VARIANT     463    463       I -> S (in CRC).',\n",
        " u'FT                                /FTId=VAR_018614.',\n",
        " u'FT   VARIANT     464    464       G -> E (in CRC).',\n",
        " u'FT                                /FTId=VAR_018615.',\n",
        " u'FT   VARIANT     464    464       G -> V (in a colorectal cancer cell line;',\n",
        " u'FT                                elevated kinase activity; efficiently',\n",
        " u'FT                                induces cell transformation).',\n",
        " u'FT                                /FTId=VAR_018616.',\n",
        " u'FT   VARIANT     466    466       G -> A (in melanoma).',\n",
        " u'FT                                /FTId=VAR_018617.',\n",
        " u'FT   VARIANT     466    466       G -> E (in melanoma).',\n",
        " u'FT                                /FTId=VAR_018618.',\n",
        " u'FT   VARIANT     466    466       G -> V (in LNCR).',\n",
        " u'FT                                /FTId=VAR_018512.',\n",
        " u'FT   VARIANT     467    467       S -> A (in CFC1).',\n",
        " u'FT                                /FTId=VAR_035096.',\n",
        " u'FT   VARIANT     468    468       F -> S (in CFC1).',\n",
        " u'FT                                /FTId=VAR_035097.',\n",
        " u'FT   VARIANT     469    469       G -> A (in NHL; also in a lung',\n",
        " u'FT                                adenocarcinoma sample; somatic mutation;',\n",
        " u'FT                                elevated kinase activity; efficiently',\n",
        " u'FT                                induces cell transformation).',\n",
        " u'FT                                /FTId=VAR_018620.',\n",
        " u'FT   VARIANT     469    469       G -> E (in CFC1 and colon cancer).',\n",
        " u'FT                                /FTId=VAR_018621.',\n",
        " u'FT   VARIANT     469    469       G -> R (in NHL).',\n",
        " u'FT                                /FTId=VAR_018622.',\n",
        " u'FT   VARIANT     469    469       G -> V (in a colorectal adenocarcinoma',\n",
        " u'FT                                sample; somatic mutation).',\n",
        " u'FT                                /FTId=VAR_040392.',\n",
        " u'FT   VARIANT     485    485       L -> F (in CFC1).',\n",
        " u'FT                                /FTId=VAR_026115.',\n",
        " u'FT   VARIANT     499    499       K -> E (in CFC1).',\n",
        " u'FT                                /FTId=VAR_026116.',\n",
        " u'FT   VARIANT     499    499       K -> N (in CFC1).',\n",
        " u'FT                                /FTId=VAR_058625.',\n",
        " u'FT   VARIANT     501    501       E -> G (in CFC1).',\n",
        " u'FT                                /FTId=VAR_026117.',\n",
        " u'FT   VARIANT     501    501       E -> K (in CFC1).',\n",
        " u'FT                                /FTId=VAR_026118.',\n",
        " u'FT   VARIANT     525    525       L -> P (in CFC1).',\n",
        " u'FT                                /FTId=VAR_058626.',\n",
        " u'FT   VARIANT     531    531       W -> C (in NS7).',\n",
        " u'FT                                /FTId=VAR_058627.',\n",
        " u'FT   VARIANT     580    580       N -> D (in CFC1).',\n",
        " u'FT                                /FTId=VAR_065173.',\n",
        " u'FT   VARIANT     581    581       N -> D (in CFC1).',\n",
        " u'FT                                /FTId=VAR_026119.',\n",
        " u'FT   VARIANT     581    581       N -> S (in a colorectal adenocarcinoma',\n",
        " u'FT                                sample; somatic mutation).',\n",
        " u'FT                                /FTId=VAR_040393.',\n",
        " u'FT   VARIANT     586    586       E -> K (in ovarian cancer).',\n",
        " u'FT                                /FTId=VAR_018623.',\n",
        " u'FT   VARIANT     594    594       D -> G (in NHL).',\n",
        " u'FT                                /FTId=VAR_018624.',\n",
        " u'FT   VARIANT     595    595       F -> L (in colon cancer and CFC1).',\n",
        " u'FT                                /FTId=VAR_018625.',\n",
        " u'FT   VARIANT     596    596       G -> R (in a colorectal adenocarcinoma',\n",
        " u'FT                                sample; somatic mutation).',\n",
        " u'FT                                /FTId=VAR_018626.',\n",
        " u'FT   VARIANT     596    596       G -> V (in CFC1).',\n",
        " u'FT                                /FTId=VAR_035098.',\n",
        " u'FT   VARIANT     597    597       L -> R (in LNCR; also found in an ovarian',\n",
        " u'FT                                serous carcinoma sample; somatic',\n",
        " u'FT                                mutation).',\n",
        " u'FT                                /FTId=VAR_018513.',\n",
        " u'FT   VARIANT     597    597       L -> V (in NS7; also in a lung',\n",
        " u'FT                                adenocarcinoma sample; somatic mutation;',\n",
        " u'FT                                elevated kinase activity; efficiently',\n",
        " u'FT                                induces cell transformation).',\n",
        " u'FT                                /FTId=VAR_018627.',\n",
        " u'FT   VARIANT     599    599       T -> R (in CFC1).',\n",
        " u'FT                                /FTId=VAR_058628.',\n",
        " u'FT   VARIANT     600    600       V -> D (in a melanoma cell line; requires',\n",
        " u'FT                                2 nucleotide substitutions).',\n",
        " u'FT                                /FTId=VAR_018628.',\n",
        " u'FT   VARIANT     600    600       V -> E (in CRC; also found in sarcoma,',\n",
        " u'FT                                metastatic melanoma, ovarian serous',\n",
        " u'FT                                carcinoma, pilocytic astrocytoma; somatic',\n",
        " u'FT                                mutation; most common mutation;',\n",
        " u'FT                                constitutive and elevated kinase',\n",
        " u'FT                                activity; efficiently induces cell',\n",
        " u'FT                                transformation; suppression of mutation',\n",
        " u'FT                                in melanoma causes growth arrest and',\n",
        " u'FT                                promotes apoptosis; loss of regulation by',\n",
        " u'FT                                PMRT5).',\n",
        " u'FT                                /FTId=VAR_018629.',\n",
        " u'FT   VARIANT     601    601       K -> E (in CRC).',\n",
        " u'FT                                /FTId=VAR_018630.',\n",
        " u'FT   VARIANT     601    601       K -> Q (in CFC1).',\n",
        " u'FT                                /FTId=VAR_058629.',\n",
        " u'FT   VARIANT     638    638       D -> E (in CFC1).',\n",
        " u'FT                                /FTId=VAR_058630.',\n",
        " u'FT   VARIANT     709    709       Q -> R (in CFC1).',\n",
        " u'FT                                /FTId=VAR_058631.',\n",
        " u'FT   MUTAGEN     483    483       K->S: Reduces kinase activity with',\n",
        " u'FT                                MAP2K1.',\n",
        " u'FT   MUTAGEN     578    578       K->R: Blocks EGF-induced ubiquitination',\n",
        " u'FT                                and ERK activation.',\n",
        " u'FT   MUTAGEN     671    671       R->K: Increased kinase activity and',\n",
        " u'FT                                stability in response to EGF treatment.',\n",
        " u'FT   CONFLICT    766    766       H -> D (in Ref. 11; AAA96495).',\n",
        " u'FT   STRAND      156    161',\n",
        " u'FT   TURN        162    164',\n",
        " u'FT   STRAND      165    170',\n",
        " u'FT   HELIX       177    186',\n",
        " u'FT   TURN        187    189',\n",
        " u'FT   HELIX       192    194',\n",
        " u'FT   STRAND      195    199',\n",
        " u'FT   STRAND      206    208',\n",
        " u'FT   HELIX       214    217',\n",
        " u'FT   STRAND      221    226',\n",
        " u'FT   STRAND      458    465',\n",
        " u'FT   STRAND      467    486',\n",
        " u'FT   STRAND      487    489',\n",
        " u'FT   HELIX       492    505',\n",
        " u'FT   STRAND      516    520',\n",
        " u'FT   STRAND      522    524',\n",
        " u'FT   STRAND      526    530',\n",
        " u'FT   STRAND      534    536',\n",
        " u'FT   HELIX       537    541',\n",
        " u'FT   TURN        542    544',\n",
        " u'FT   HELIX       550    569',\n",
        " u'FT   STRAND      581    585',\n",
        " u'FT   TURN        586    588',\n",
        " u'FT   STRAND      589    592',\n",
        " u'FT   STRAND      599    601',\n",
        " u'FT   HELIX       617    619',\n",
        " u'FT   HELIX       622    625',\n",
        " u'FT   STRAND      629    631',\n",
        " u'FT   HELIX       635    651',\n",
        " u'FT   TURN        655    658',\n",
        " u'FT   HELIX       662    670',\n",
        " u'FT   HELIX       678    680',\n",
        " u'FT   STRAND      683    685',\n",
        " u'FT   HELIX       687    696',\n",
        " u'FT   HELIX       701    703',\n",
        " u'FT   HELIX       707    716',\n",
        " u'FT   HELIX       718    720',\n",
        " u'SQ   SEQUENCE   766 AA;  84437 MW;  0798C2AAB487E813 CRC64;',\n",
        " u'     MAALSGGGGG GAEPGQALFN GDMEPEAGAG AGAAASSAAD PAIPEEVWNI KQMIKLTQEH',\n",
        " u'     IEALLDKFGG EHNPPSIYLE AYEEYTSKLD ALQQREQQLL ESLGNGTDFS VSSSASMDTV',\n",
        " u'     TSSSSSSLSV LPSSLSVFQN PTDVARSNPK SPQKPIVRVF LPNKQRTVVP ARCGVTVRDS',\n",
        " u'     LKKALMMRGL IPECCAVYRI QDGEKKPIGW DTDISWLTGE ELHVEVLENV PLTTHNFVRK',\n",
        " u'     TFFTLAFCDF CRKLLFQGFR CQTCGYKFHQ RCSTEVPLMC VNYDQLDLLF VSKFFEHHPI',\n",
        " u'     PQEEASLAET ALTSGSSPSA PASDSIGPQI LTSPSPSKSI PIPQPFRPAD EDHRNQFGQR',\n",
        " u'     DRSSSAPNVH INTIEPVNID DLIRDQGFRG DGGSTTGLSA TPPASLPGSL TNVKALQKSP',\n",
        " u'     GPQRERKSSS SSEDRNRMKT LGRRDSSDDW EIPDGQITVG QRIGSGSFGT VYKGKWHGDV',\n",
        " u'     AVKMLNVTAP TPQQLQAFKN EVGVLRKTRH VNILLFMGYS TKPQLAIVTQ WCEGSSLYHH',\n",
        " u'     LHIIETKFEM IKLIDIARQT AQGMDYLHAK SIIHRDLKSN NIFLHEDLTV KIGDFGLATV',\n",
        " u'     KSRWSGSHQF EQLSGSILWM APEVIRMQDK NPYSFQSDVY AFGIVLYELM TGQLPYSNIN',\n",
        " u'     NRDQIIFMVG RGYLSPDLSK VRSNCPKAMK RLMAECLKKK RDERPLFPQI LASIELLARS',\n",
        " u'     LPKIHRSASE PSLNRAGFQT EDFSLYACAS PKTPIQAGGY GAFPVH',\n",
        " u'//',\n",
        " u'ID   RASK_HUMAN              Reviewed;         189 AA.',\n",
        " u'AC   P01116; A8K8Z5; B0LPF9; P01118; Q96D10;',\n",
        " u'DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.',\n",
        " u'DT   21-JUL-1986, sequence version 1.',\n",
        " u'DT   09-JUL-2014, entry version 178.',\n",
        " u'DE   RecName: Full=GTPase KRas;',\n",
        " u'DE   AltName: Full=K-Ras 2;',\n",
        " u'DE   AltName: Full=Ki-Ras;',\n",
        " u'DE   AltName: Full=c-K-ras;',\n",
        " u'DE   AltName: Full=c-Ki-ras;',\n",
        " u'DE   Contains:',\n",
        " u'DE     RecName: Full=GTPase KRas, N-terminally processed;',\n",
        " u'DE   Flags: Precursor;',\n",
        " u'GN   Name=KRAS; Synonyms=KRAS2, RASK2;',\n",
        " u'OS   Homo sapiens (Human).',\n",
        " u'OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;',\n",
        " u'OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;',\n",
        " u'OC   Catarrhini; Hominidae; Homo.',\n",
        " u'OX   NCBI_TaxID=9606;',\n",
        " u'RN   [1]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2A AND 2B).',\n",
        " u'RX   PubMed=6308466; DOI=10.1038/304501a0;',\n",
        " u'RA   McGrath J.P., Capon D.J., Smith D.H., Chen E.Y., Seeburg P.H.,',\n",
        " u'RA   Goeddel D.V., Levinson A.D.;',\n",
        " u'RT   \"Structure and organization of the human Ki-ras proto-oncogene and a',\n",
        " u'RT   related processed pseudogene.\";',\n",
        " u'RL   Nature 304:501-506(1983).',\n",
        " u'RN   [2]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2A AND 2B).',\n",
        " u'RC   TISSUE=Lung carcinoma;',\n",
        " u'RX   PubMed=6308465; DOI=10.1038/304497a0;',\n",
        " u'RA   Shimizu K., Birnbaum D., Ruley M.A., Fasano O., Suard Y., Edlund L.,',\n",
        " u'RA   Taparowsky E., Goldfarb M., Wigler M.;',\n",
        " u'RT   \"Structure of the Ki-ras gene of the human lung carcinoma cell line',\n",
        " u'RT   Calu-1.\";',\n",
        " u'RL   Nature 304:497-500(1983).',\n",
        " u'RN   [3]',\n",
        " u'RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2A AND 2B).',\n",
        " u'RC   TISSUE=Colon carcinoma, and Lung;',\n",
        " u'RX   PubMed=6308467; DOI=10.1038/304507a0;',\n",
        " u'RA   Capon D.J., Seeburg P.H., McGrath J.P., Hayflick J.S., Edman U.,',\n",
        " u'RA   Levinson A.D., Goeddel D.V.;',\n",
        " u'RT   \"Activation of Ki-ras2 gene in human colon and lung carcinomas by two',\n",
        " u'RT   different point mutations.\";',\n",
        " ...]"
       ]
      }
     ],
     "prompt_number": 11
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "key = None\n",
      "with (tag, seq) for (t[:5].strip(), t[5:].strip()) in uni_txt.splitlines():\n",
      "    if tag and tag != key:\n",
      "        key = tag\n",
      "    value = seq.split()\n",
      "    \n",
      "    \n",
      "        "
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "ename": "SyntaxError",
       "evalue": "invalid syntax (<ipython-input-16-f833d9e8fdf6>, line 2)",
       "output_type": "pyerr",
       "traceback": [
        "\u001b[0;36m  File \u001b[0;32m\"<ipython-input-16-f833d9e8fdf6>\"\u001b[0;36m, line \u001b[0;32m2\u001b[0m\n\u001b[0;31m    with (tag, seq) for (t[:5].strip(), t[5:].strip()) in uni_txt.splitlines():\u001b[0m\n\u001b[0m                      ^\u001b[0m\n\u001b[0;31mSyntaxError\u001b[0m\u001b[0;31m:\u001b[0m invalid syntax\n"
       ]
      }
     ],
     "prompt_number": 16
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "def get_parts(uni_txt):\n",
      "    for line in uni_txt.splitlines():\n",
      "        k, v = line[:5].strip(), line[5:].strip()\n",
      "        return k, v.split()\n",
      "    \n",
      "x = get_parts(uni_txt)\n",
      "for (a,b) as (a,b) in x:\n",
      "    type(a)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "ename": "SyntaxError",
       "evalue": "invalid syntax (<ipython-input-29-7bfa385e2d1a>, line 7)",
       "output_type": "pyerr",
       "traceback": [
        "\u001b[0;36m  File \u001b[0;32m\"<ipython-input-29-7bfa385e2d1a>\"\u001b[0;36m, line \u001b[0;32m7\u001b[0m\n\u001b[0;31m    for (a,b) as (a,b) in x:\u001b[0m\n\u001b[0m               ^\u001b[0m\n\u001b[0;31mSyntaxError\u001b[0m\u001b[0;31m:\u001b[0m invalid syntax\n"
       ]
      }
     ],
     "prompt_number": 29
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "metadata_by_acc = {}\n",
      "key = None\n",
      "for tag, words in [get_parts(uni_txt)]:\n",
      "    if tag and tag != key:\n",
      "        key = tag\n",
      "    if tag == \"ID\":\n",
      "        uniprot_id = words[0]\n",
      "        is_reviewed = words[1].startswith('Reviewed')\n",
      "        length = int(words[2])\n",
      "        metadata_by_acc[uniprot_id] = {\n",
      "            'id': uniprot_id,\n",
      "            'is_reviewed': is_reviewed,\n",
      "            'length': length,\n",
      "            'sequence': '',\n",
      "            'accs': [],\n",
      "            'gene': [],\n",
      "        }\n",
      "        entry = metadata_by_acc[uniprot_id]\n",
      "print metadata_by_acc\n",
      "    "
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "{u'BRAF_HUMAN': {'is_reviewed': True, 'sequence': '', 'length': 766, 'gene': [], 'id': u'BRAF_HUMAN', 'accs': []}}\n"
       ]
      }
     ],
     "prompt_number": 33
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "for l in uni_txt.splitlines():\n",
      "    ttag = l[:5].strip()\n",
      "type(ttag)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 23,
       "text": [
        "unicode"
       ]
      }
     ],
     "prompt_number": 23
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "#def get_parts(uni_txt_split):\n",
      "    #for line in uni_txt_split:\n",
      "     #   k, v = [line[:5].strip(), line[5:].strip()]\n",
      "      #  return k, v.split()\n",
      "\n",
      "def parse_uniprot(uni_txt):\n",
      "    \"\"\"Parse metadata text from uniprot.org\n",
      "\n",
      "     Returns a dictionary with the UNIPROT ACC as keys.\n",
      "     \"\"\"\n",
      "    uniprot_id = None\n",
      "    metadata_by_acc = {}\n",
      "    key = None\n",
      "    for line in uni_txt.splitlines():\n",
      "        tag = line[:5].strip()\n",
      "        #k, v = [line[:5].strip(), line[5:].strip()]\n",
      "        if tag and tag != key:\n",
      "            key = tag\n",
      "        words = line[5:].strip().split()\n",
      "        if key == \"ID\":\n",
      "            uniprot_id = words[0]\n",
      "            is_reviewed = words[1].startswith('Reviewed')\n",
      "            length = int(words[2])\n",
      "            metadata_by_acc[uniprot_id] = {\n",
      "                'id': uniprot_id,\n",
      "                'is_reviewed': is_reviewed,\n",
      "                'length': length,\n",
      "                'sequence': '',\n",
      "                'accs': [],\n",
      "                'gene': [],\n",
      "            }\n",
      "            entry = metadata_by_acc[uniprot_id]\n",
      "        return metadata_by_acc\n",
      "\n",
      "\n",
      "def pull_uni(ids, format='txt'):\n",
      "    \"\"\" request entries by uniprot acc using batch retrieval\n",
      "    Args:\n",
      "        ids: list of ids to retrieve\n",
      "        format: txt by default\n",
      "        possible formats:\n",
      "        txt, xml, rdf, fasta, gff\"\"\"\n",
      "\n",
      "    tool = 'batch/'\n",
      "    if type(ids) is not list:\n",
      "        ids = [ids]\n",
      "    query = ' '.join(ids)\n",
      "    query = list(set(query.split()))\n",
      "    queries = [query[i:i + 100] for i in xrange(0, len(query), 100)]\n",
      "    data = {'format': format}\n",
      "    responses = [\n",
      "        requests.post(url + tool, data=data, files={'file': ' '.join(query)}) for query in queries]\n",
      "    uni_txt = ''.join([response.text for response in responses])\n",
      "    #return uni_txt\n",
      "    res = parse_uniprot(uni_txt)\n",
      "    return res\n",
      "\n",
      "import sys\n",
      "import pprint\n",
      "\n",
      "if __name__ == '__main__':\n",
      "    ids = ['P01116', 'P15056']\n",
      "    res = pull_uni(ids)\n",
      "    pprint.pprint(res)\n"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "{u'BRAF_HUMAN': {'accs': [],\n",
        "                 'gene': [],\n",
        "                 'id': u'BRAF_HUMAN',\n",
        "                 'is_reviewed': True,\n",
        "                 'length': 766,\n",
        "                 'sequence': ''}}\n"
       ]
      }
     ],
     "prompt_number": 42
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": []
    }
   ],
   "metadata": {}
  }
 ]
}